# EDGAR Filing Document

**Accession Number:** 0001819794
**File Stem:** 0001493152-26-007262
**Filing Date:** 2026-2
**Character Count:** 196390
**Document Hash:** 750e1208d966799d7f4a8357937027c1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-007262.hdr.sgml**: 20260218

**ACCESSION NUMBER**: 0001493152-26-007262

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20260218

**FILED AS OF DATE**: 20260218

**DATE AS OF CHANGE**: 20260218

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fusion Fuel Green PLC
- **CENTRAL INDEX KEY:** 0001819794
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39789
- **FILM NUMBER:** 26645441

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 10 EARLSFORT TERRACE
- **STREET 2:** DUBLIN 2
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 351 21 581 8802

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 10 EARLSFORT TERRACE
- **STREET 2:** DUBLIN 2
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Fusion Fuel Green Ltd
- **DATE OF NAME CHANGE:** 20200731

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of: **February, 2026.**

Commission File Number: **001-39789**

**Fusion Fuel Green PLC**

(Translation of registrant's name into English)

**9 Pembroke Street Upper**

**Dublin D02 KR83**

**Ireland**<br> (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

On February 18, 2026, Fusion Fuel Green PLC, an Irish public limited company (the "Company"), entered into a Share Exchange Agreement (the "Share Exchange Agreement"), dated as of February 18, 2026, among the Company and certain shareholders (the "RU Shareholders") of Royal Uranium Inc., a company incorporated under the laws of British Columbia, Canada ("Royal Uranium").

Pursuant to the Share Exchange Agreement, the RU Shareholders will sell up to 100% of the issued and outstanding shares in the capital of Royal Uranium (78,581,029 common shares) to the Company in exchange for up to 3,750,025 Class A Ordinary Shares of the Company with nominal value $0.0035 per share ("Class A Ordinary Shares") or pre-funded warrants ("Pre-Funded Warrants") to subscribe for up to such number of Class A Ordinary Shares (at an exercise price per share equal to the nominal value of the shares) in lieu of the Class A Ordinary Shares to the extent that the allotment of Class A Ordinary Shares would result in such shareholders' beneficial ownership of shares in the Company exceeding 9.99% of the issued share capital of the Company (the "Securities Exchange"). The Securities Exchange will result in Royal Uranium becoming a subsidiary of the Company. The Share Exchange Agreement provides that Royal Uranium is valued at $15,000,000.

The closing of the Securities Exchange (the "Closing") will take place electronically on the third business day following satisfaction or waiver of all conditions to consummate the Securities Exchange or such other date and time as the parties may mutually determine. The Share Exchange Agreement provides that if, within 30 days following the date of the Share Exchange Agreement, subject to extension by agreement between the Company and Anthony Milewski and Mark Schipperheijn (each of whom is an RU Shareholder, and together, the "Representative Shareholders"), RU Shareholders holding not less than 75% of the issued shares in Royal Uranium have not signed the Share Exchange Agreement or a joinder thereto, the Company may elect to implement the Securities Exchange by way of a plan of arrangement or in such other manner as may be permitted by Canadian law.

The Closing is subject to certain conditions, including: (i) that no temporary restraining order, preliminary or permanent injunction issued by any court of competent jurisdiction preventing or prohibiting the consummation of the Securities Exchange shall be in effect; (ii) that RU Shareholders holding not less than 75% of the issued shares in Royal Uranium shall have signed the Share Exchange Agreement or executed a joinder thereto; (iii) that the Company shall have obtained the requisite shareholder approval as required by the Irish Takeover Panel Act 1997, Takeover Rules, 2022 (the "Takeover Rules"); (iv) the accuracy of the representations and warranties of the parties in all material respects; (v) compliance by the parties with their covenants and agreements in all material respects; and (vi) the absence of any material adverse effect on either Royal Uranium or the Company since the date of the Share Exchange Agreement.

From and after the date of the Share Exchange Agreement until the earlier of the Closing or the termination of the Share Exchange Agreement, the Company, Royal Uranium, and each RU Shareholder shall not, directly or indirectly, (i) initiate, solicit, encourage, negotiate, accept or discuss any transaction or series of transactions with any person involving any sale of substantially all of the assets or capital stock of Royal Uranium or the Company to another acquirer (an "Alternative Acquisition"), (ii) provide information with respect to a party to any person relating to a possible Alternative Acquisition, (iii) enter into an agreement with any person providing for a possible Alternative Acquisition, or (iv) make or authorize any statement, recommendation or solicitation in support of any possible Alternative Acquisition. If any party receives any unsolicited offer, inquiry or proposal relating to an Alternative Acquisition, such party must promptly notify the other parties thereof.

The Company is required to prepare a draft circular to shareholders containing notice of an extraordinary general meeting (the "EGM") and information regarding the Securities Exchange as required by the Takeover Rules. The Company must furnish a draft of the circular to the Representative Shareholders for review within five business days of the date of the Share Exchange Agreement, submit the draft circular to the Irish Takeover Panel within three business days of receipt of input from the Representative Shareholders, and commence mailing to shareholders within five business days of the Irish Takeover Panel providing confirmation that the circular satisfies the necessary requirements under the Takeover Rules. The Company is required to use all reasonable endeavors to procure that the EGM is held, and shareholder approval of the Securities Exchange is obtained, as soon as reasonably practicable following the date of the Share Exchange Agreement.

The Share Exchange Agreement includes lock-up restrictions on the RU Shareholders with respect to the Class A Ordinary Shares. RU Shareholders (or RU Shareholders who are affiliates) who receive more than 25,000 Class A Ordinary Shares are subject to restrictions prohibiting the transfer, sale, pledge, or other disposition of the Class A Ordinary Shares as follows: (i) 100% of the Class A Ordinary Shares for six months from the date of the Share Exchange Agreement; (ii) two-thirds of the Class A Ordinary Shares for 12 months from the date of the Share Exchange Agreement; and (iii) one-third of the Class A Ordinary Shares for 18 months from the date of the Share Exchange Agreement. RU Shareholders (together with their affiliates) who receive 25,000 Class A Ordinary Shares or fewer will be released from such restrictions after six months following the date of the Share Exchange Agreement. The Company will be required to file a registration statement to register the resale of the Class A Ordinary Shares within 20 business days of the expiration of such lock-up restrictions.

The Share Exchange Agreement may be terminated prior to the Closing: (i) by mutual written agreement of the Representative Shareholders and the Company; (ii) by either party if the other party has breached any representation, warranty, covenant or agreement resulting in or reasonably expected to result in a material adverse effect or would prevent or materially delay the consummation of the Securities Exchange; (iii) by any party if all conditions to such party's obligations have not been satisfied or waived on or before the date falling 12 months from the date of the Share Exchange Agreement; or (iv) by any party if a permanent injunction or other order preventing or prohibiting consummation of the Securities Exchange has been issued and has become final and non-appealable.

In addition, the Share Exchange Agreement contains certain representations, warranties, limitations of liability, and indemnification provisions, and customary covenants.

Under each Mineral & Element Advisory Agreement, dated as of February 12, 2026 (collectively the "Advisory Agreements"), between the Company and each of three other parties (the "Advisors"), the Share Exchange Agreement will constitute a Definitive Agreement (as defined in the Advisory Agreements). The Advisory Agreements were disclosed in the Company's Report on Form 6-K furnished with the U.S. Securities and Exchange Commission on February 17, 2026 (the "Prior Form 6-K"). Pursuant to the Advisory Agreements and at the election of the Advisors, the Company will issue 95,000 Class A Ordinary Shares and customary pre-funded warrants to purchase up to an aggregate of 142,500 Class A Ordinary Shares to the Advisors in the form attached as Exhibit 4.1 to the Prior Form 6-K ("Advisor Pre-Funded Warrants"), on the first trading day after the execution of the Share Exchange Agreement, and such Class A Ordinary Shares and Class A Ordinary Shares issuable upon exercise of such Advisor Pre-Funded Warrants will be subject to certain registration requirements, as further disclosed in the Prior Form 6-K.

Prior to the entry into the Share Exchange Agreement, there were no material relationships between the Company or any of the Company's affiliates, including any director or officer of the Company, or any associate of any director or officer of the Company, and any of the RU Shareholders, except that Anthony Milewski, an RU Shareholder, purchased $250,000 of the securities purchased under the Securities Purchase Agreement, dated as of February 14, 2026, between the Company and certain investors, which was previously disclosed in the Prior Form 6-K, and is also an Advisor under one of the Advisory Agreements.

The form of Pre-Funded Warrants and the form of Share Exchange Agreement are furnished as Exhibit 4.1 and Exhibit 10.1 to this Report on Form 6-K, respectively, and the description above is qualified in its entirety by reference to the full text of such exhibit.

The offer and sale of securities described above is being conducted as a private placement pursuant to and in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder for transactions not involving a public offering.

On February 18, 2026, the Company issued a press release announcing that it had entered into the Share Exchange Agreement. A copy of the press release is furnished as Exhibit 99.1 to this Report on Form 6-K.

***Forward-Looking Statements***

The press release attached as Exhibit 99.1 hereto and the statements contained therein include "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or the Company's future financial or operating performance. In some cases, you can identify these statements because they contain words such as "may," "will," "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," "plan," "target," "predict," "potential," or the negative of such terms, or other comparable terminology that concern the Company's expectations, strategy, plans, or intentions. Forward-looking statements relating to expectations about future results or events are based upon information available to the Company as of today's date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. The Company's expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the parties' ability to complete the Share Exchange, the Company's ability to integrate Royal Uranium into its business, the ability of the parties to obtain Irish regulatory approval and any other required third-party consents and approvals in connection with the Share Exchange, obtain the approval of the Company's shareholders, and to meet all other closing conditions; the realization of revenues from the assets of Royal Uranium, including its uranium and natural gas royalties, which may depend on, among other things, the degree of success in obtaining regulatory acceptance of, and market demand for, uranium and natural gas as sources of energy; competition from existing or new offerings that may emerge; impacts from strategic changes to the Company's business on net sales, revenues, income from continuing operations, or other results of operations; the Company's ability to obtain sufficient funding to maintain operations and develop additional services and offerings; and the risks and uncertainties described under Item 3. "Key Information – D. Risk Factors" and elsewhere in the Company's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the "SEC") on May 9, 2025 (the "Annual Report"), and other filings with the SEC. Should any of these risks or uncertainties materialize, or should the underlying assumptions about the Company's business and the commercial markets in which the Company operates prove incorrect, actual results may vary materially from those described as anticipated, estimated or expected in the Annual Report. All subsequent written and oral forward-looking statements concerning the Company or other matters and attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. The Company does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof, except as required by law.

This Report on Form 6-K is incorporated by reference into the Company's registration statements on Form F-3 (File [333-287226](https://www.sec.gov/Archives/edgar/data/1819794/000121390025042661/ea0241672-f3_fusion.htm), [333-289429](https://www.sec.gov/Archives/edgar/data/1819794/000164117225022763/formf-3.htm), [333-286198](https://www.sec.gov/Archives/edgar/data/1819794/000101376225003518/ea0235793-f3_fusion.htm), [333-286202](https://www.sec.gov/Archives/edgar/data/1819794/000101376225003512/ea0235791-f3_fusion.htm), [333-251990](https://www.sec.gov/Archives/edgar/data/1819794/000117184322005419/posam_080522.htm), [333-264714](https://www.sec.gov/Archives/edgar/data/1819794/000117184322003338/ff3_042822.htm), [333-276880](https://www.sec.gov/Archives/edgar/data/1819794/000117184324000607/f3_020424.htm), and [333-293286](https://www.sec.gov/Archives/edgar/data/1819794/000149315226005635/formf-3.htm)) and Form S-8 (File Nos. [333-258543](https://www.sec.gov/Archives/edgar/data/1819794/000121390021040682/ea145212-s8_fusionfuel.htm) and [333-291732](https://www.sec.gov/Archives/edgar/data/1819794/000149315225024692/forms-8.htm)) and the prospectuses thereof and any prospectus supplements or amendments thereto.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 4.1 | [Form of Pre-Funded Ordinary Shares Purchase Warrant issuable pursuant to the Share Exchange Agreement, dated as of February 18, 2026, between Fusion Fuel Green PLC and the other parties signatory thereto](ex4-1.htm) |
| 10.1 | [Form of Share Exchange Agreement, dated as of February 18, 2026, between Fusion Fuel Green PLC and the other parties signatory thereto](ex10-1.htm) |
| 99.1 | [Press release dated February 18, 2026](ex99-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **Fusion Fuel Green PLC** |
|  | (Registrant) |
| Date: February 18, 2026 | */s/ John-Paul Backwell* |
|  | John-Paul Backwell |
|  | Chief Executive Officer |

---

## Exhibit 4.1

**Exhibit 4.1**

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE AND THIS SECURITY WAS ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") AND SIMILAR EXEMPTIONS UNDER APPLICABLE STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN "ACCREDITED INVESTOR" AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

**PRE-FUNDED ORDINARY SHARES PURCHASE WARRANT**

**FUSION FUEL GREEN PLC** 

Warrant Shares: [__]

This PRE-FUNDED ORDINARY SHARES PURCHASE WARRANT (this "<u>Warrant</u>"), dated [__], 2026, certifies that, for value received, [__] or its assigns (the "<u>Holder</u>") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time from and after the date hereof (the "<u>Initial Exercise Date</u>") and until this Warrant is exercised in full (the "<u>Termination Date</u>") but not thereafter, to subscribe for and purchase from Fusion Fuel Green PLC, a public limited company incorporated in Ireland (the "<u>Company</u>"), up to [__] Class A ordinary shares of the Company, with a nominal value of $0.0035 each (a "<u>Share</u>" and, collectively, the "<u>Shares</u>") (as subject to adjustment hereunder, the "<u>Warrant Shares</u>"). The purchase price of one Share under this Warrant shall be equal to the Exercise Price, as defined in <u>Section 2(b)</u>.

<u>Section 1</u>. [Reserved]

<u>Section 2</u>. <u>Exercise</u>**.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by email (or email attachment) of the Notice of Exercise in the form annexed hereto (the "<u>Notice of Exercise</u>"). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date the Holder delivers the Notice of Exercise, the Holder shall deliver to the Company the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier's check drawn on a United States bank. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver to the Holder any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. **The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.** For purposes hereof, a "**Trading Day**" is a day on which the Shares are traded on a Trading Market.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) <u>Exercise Price</u>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0035 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0035 per Warrant Share) shall be required to be paid by the Holder to any person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per Share under this Warrant shall be $0.0035 (the "<u>Exercise Price</u>").

"<u>Trading Market</u>" means any of the following markets or exchanges on which the Shares are listed or quoted for trading on the date in question: the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the OTCQX, or the OTCQB.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Mechanics of Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. <u>Delivery of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Company's transfer agent ("<u>Transfer Agent</u>") to the Holder by crediting the account of the Holder's or its designee's balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system ("<u>DWAC</u>") if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company's share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the "<u>Warrant Share Delivery Date</u>"). <u>provided</u>, <u>however</u>, that if payment of the aggregate Exercise Price is received after 12:00 P.M., New York City time on the Warrant Share Delivery Date, then the Warrant Share Delivery Date shall be extended by one (1) additional Trading Day. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, "<u>Standard Settlement Period</u>" means the standard settlement period, expressed in a number of Trading Days, on the Company's primary Trading Market with respect to the Shares as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Securities Purchase Agreement, the Company agrees to use reasonable efforts to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the date following the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price is received by such Warrant Share Delivery Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. <u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round up to the next whole share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vi. <u>Charges, Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>, <u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vii. <u>Closing of Books</u>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;viii. [Reserved]

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Holder's Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder's affiliates, and any other persons acting as a group together with the Holder or any of the Holder's affiliates (such persons, "<u>Attribution Parties</u>")), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of Shares beneficially owned by the Holder and its affiliates and Attribution Parties shall include the number of Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Shares which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant beneficially owned by the Holder or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or non-converted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred share or warrants, including other Warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>") and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder's determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall not have an obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding Shares, a Holder may rely on the number of outstanding Shares as reflected in (A) the Company's most recent periodic or annual report filed with the Securities and Exchange Commission (the "<u>Commission</u>"), as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Shares outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of Shares then outstanding. In any case, the number of outstanding Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its affiliates or Attribution Parties since the date as of which such number of outstanding Shares was reported. The "<u>Beneficial Ownership Limitation</u>" shall be 4.99% of the number of Shares outstanding immediately after giving effect to the issuance of Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Shares outstanding immediately after giving effect to the issuance of Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup>st</sup> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

<u>Section 3</u>. <u>Certain Adjustments</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>Share Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a distribution or distributions on its Shares or any other equity or equity equivalent securities payable in Shares (which, for avoidance of doubt, shall not include any Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding Shares into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding Shares into a smaller number of shares, or (iv) reclassification of its shares solely into another class of shares then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be adjusted solely to maintain the holder's proportionate interest such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) The Holder shall not be entitled to participate in any cash dividends, distributions of assets, spin-offs, rights offerings, or other corporate distributions made to holders of Shares, except for strictly proportional adjustments to the Exercise Price and number of Warrant Shares required under Section 3(b). No other adjustment shall be made under this Section 3(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) In the event of a merger, consolidation, reorganization, or other transaction in which the Company's Shares are converted solely into the right to receive other equity securities of the Company or its successor, this Warrant shall be adjusted only as strictly required to preserve the Holder's proportional interest as set forth in Section 3(c). No cash, property, or other non-equity consideration shall be issuable upon exercise of this Warrant, and no adjustment shall be made based on market value, intrinsic value, or economic equivalence. The successor entity shall assume this Warrant solely with respect to delivering a fixed number of equity securities upon exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Calculations</u>. All calculations under this Section 3 shall be made by the Company to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Shares (excluding treasury shares, if any) issued and outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) <u>Notice to Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. <u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this <u>Section 3</u>, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. <u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Shares, (C) the Company shall authorize the granting to all holders of the Shares rights or warrants to subscribe for or purchase any shares of capital of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Shares, any consolidation or merger to which the Company (or any of its material subsidiaries) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Shares are converted into other securities, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of Shares of record shall be entitled to exchange their Shares for securities, deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the material subsidiaries, the Company shall simultaneously file or furnish such notice with the Commission pursuant to a Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

<u>Section 4</u>. <u>Transfer of Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>Transferability</u>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Securities Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the office of the Company designated for such purpose, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an Assignment Form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) <u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the "<u>Warrant Register</u>"), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Transfer Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, deliver an unqualified opinion of counsel issued to the Company and reasonably acceptable to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>e) Representation by the Holder</u>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

<u>Section 5</u>. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>No Rights as Shareholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise of this Warrant, except as expressly set forth in Section 3. In no event shall the Company be required to net cash settle any exercise of this Warrant, and the Company shall only be required to deliver Warrant Shares upon exercise in accordance with this Warrant..

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Authorized Shares</u>.

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its constitution or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) <u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. The Company and the Holder agree that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company, the Holder or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan. The Company and the Holder each irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in New York, New York for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Warrant), and hereby irrevocably waives, and agrees not to assert in any action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and the Holder each irrevocably waives personal service of process and consents to process being served in any such action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If the Company or the Holder shall commence an action or proceeding to enforce any provisions of this Warrant, the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys' fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) <u>Restrictions</u>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g) <u>Non-waiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder's rights, powers or remedies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h) <u>Notices</u>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Securities Purchase Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i) <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j) <u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k) <u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l) <u>Amendment</u>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m) <u>Severability</u>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n) <u>Headings</u>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

**IN WITNESS WHEREOF**, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

---

| | |
|:---|:---|
| **FUSION FUEL GREEN PLC** | **FUSION FUEL GREEN PLC** |
| By: |  |
| Name: | John-Paul Backwell |
| Title: | Chief Executive Officer |

---

**NOTICE OF EXERCISE**

TO: FUSION FUEL GREEN PLC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Payment shall take the form of lawful money of the United States.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

The Warrant Shares shall be delivered to the following DWAC Account Number:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) <u>Accredited Investor</u>. The undersigned is an "accredited investor" as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity: ___________________________________________________________________________

*Signature of Authorized Signatory of Investing Entity*: _____________________________________________________

Name of Authorized Signatory: _______________________________________________________________________

Title of Authorized Signatory: ________________________________________________________________________

Date: ___________________________________________________________________________________________

**ASSIGNMENT FORM**

*(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)*

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

Name: ___________________________________

Address:_________________________________________________________________________________________

Phone Number: ____________________________ <br>Email Address: _____________________________

Dated: _________________ ___, _______

Holder's Signature: __________________________ <br>Holder's Address: ___________________________

## Exhibit 10.1

**Exhibit 10.1**

**SHARE EXCHANGE AGREEMENT**

This **SHARE EXCHANGE AGREEMENT** (the "**Agreement**") is made and entered into as of February ____ 2026, by and among Fusion Fuel Green Public Limited Company, a company duly incorporated and existing under the laws of Ireland and having its shares listed on the Nasdaq stock exchange (the "**Company**"), and the shareholders of Royal Uranium Inc. who are signatories to this Agreement, together with all shareholders that sign a joinder to this Agreement to become bound by the terms hereof (collectively, the "**RU Shareholders**"), a company duly incorporated and existing under the laws of British Columbia, Canada ("**Royal Uranium**"). Capitalised terms used in this Agreement are defined in Annex 1 attached hereto.

**WHEREAS**, the Company wishes to acquire Royal Uranium and the RU Shareholders wish to exchange their shares in Royal Uranium for shares in the Company;

**WHEREAS**, for the purposes of the acquisition and calculation of the consideration, Royal Uranium is valued at USD 15,000,000 (the "**Purchase Price**");

**WHEREAS**, in furtherance of the foregoing, it is agreed that the RU Shareholders will sell up to one hundred percent (100%) of the issued and outstanding shares in the capital of Royal Uranium issued and outstanding as at the Closing Date, being 78,581,029 common shares (the "**Royal Uranium Shares**"), to the Company, in consideration for the allotment and issuance by the Company to the RU Shareholders of up to 3,750,025 ordinary shares in the capital of the Company, in accordance with each RU Shareholder's respective allocation as set out in Annex 2 (the "**HTOO Shares**") (the "**Share Exchange**") (the "**Transaction**");

**WHEREAS**, immediately following the closing of the Transaction contemplated by this Agreement, the Company shall own up to one hundred percent (100%) of the share capital and voting rights of Royal Uranium and thus Royal Uranium shall become a subsidiary of the Company;

**WHEREAS**, both the board of directors of the Company and of Royal Uranium have each determined that it is desirable and in the best interests of their respective shareholders of their respective companies to effect the Share Exchange;

**NOW, THEREFORE**, in consideration of the foregoing and the mutual promises, representations, warranties, covenants and agreements herein contained, the parties hereto, intending to be legally bound, hereby agree as follows:

**ARTICLE I**

1. **EXCHANGE OF SHARES** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1** **Exchange of Shares** 

At the Closing: (i) each RU Shareholder shall sell, transfer, convey and deliver to the Company the Royal Uranium Shares it owns free and clear of all Liens, in consideration for which the Company shall allot and issue to each such RU Shareholder the HTOO Shares, free and clear of all Liens (other than the restrictions imposed by Section 7 of this Agreement), in the proportions set out in Annex 2; and (ii) each party shall deliver any other closing deliverables required by this Agreement, including the certificates (if any) or instruments evidencing the transfer of the Royal Uranium Shares.

Each RU Shareholder may elect to receive pre-funded warrants to subscribe for shares in the Company (at an exercise price per share equal to the nominal value of the shares) in lieu of the HTOO Shares but only to the extent that the allotment to any of them of HTOO Shares would result in their beneficial holding of shares in the Company exceeding 9.99% of the issued share capital of the Company. Such right of election shall only exist in respect of such number of shares in the Company as would result in their beneficial holding exceeding the aforementioned 9.99% threshold, and the aforementioned RU Shareholders shall be required to accept the allotment of HTOO Shares pursuant to this Agreement up to such 9.99% threshold.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2** **Closing** 

The closing (the "**Closing**") of the Transaction contemplated by this Agreement shall take place electronically on the third Business Day following satisfaction or waiver of all conditions and obligations of the parties to consummate the Transaction contemplated hereby (other than conditions and obligations with respect to the actions that the respective parties will take at Closing) or such other date and time as the parties may mutually determine (the "**Closing Date**"). All documents shall be exchanged electronically in portable document format (.pdf), or other mutually agreed electronic format, save for documents required by law or as otherwise agreed by the parties to be delivered in hard copy at the offices of the counsel to the Company. Electronic delivery of documents shall be deemed effective upon transmission to the email addresses specified in Section 10.1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.3** **Company Election** 

If, within a period of 30 days following the date of this Agreement (subject to such extension as may be agreed between the Company and the Representative Shareholders), RU Shareholders holding not less than 75% of the issued shares in the capital of Royal Uranium have not signed this Agreement or a joinder to this Agreement in the form attached as Annex 3 to this Agreement, the Company may elect to implement the Transaction by way of a plan of arrangement or in such other manner as may be permitted by Canadian Law (subject in all instances to such corporate and shareholder approvals as may be required on the part of the Company and the RU Shareholders), rather than by way of the Share Exchange.

**ARTICLE II**

2. **REPRESENTATIONS AND WARRANTIES IN RESPECT OF RU SHAREHOLDERS** 

Each of the RU Shareholders represent and warrant severally (and not jointly) to the Company that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1** **Authority; Noncontravention** 

Such RU Shareholder has all requisite corporate (if it is a corporation) and other power and authority to enter into this Agreement and to consummate the Transaction. The execution and delivery of this Agreement by such RU Shareholder and the consummation by the RU Shareholder of the Transaction have been (or at Closing will have been) duly authorised by all necessary corporate action (if it is a corporation) on the part of such RU Shareholder. This Agreement has been duly executed and when delivered by such RU Shareholder shall constitute valid and binding obligations of such RU Shareholder, enforceable against such RU Shareholder in accordance with its terms, except as such enforcement may be limited by bankruptcy, insolvency or other similar Laws affecting the enforcement of creditors' rights generally or by general principles of equity. The execution and delivery of this Agreement do not, and the consummation of the Share Exchange and compliance with the provisions hereof will not, conflict with, or result in any breach or violation of, or Default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of or "put" right with respect to any obligation or to a loss of a material benefit under, or result in the creation of any Lien upon any of the Assets of Royal Uranium.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.2** **Governmental Authorisation** 

No consent, approval, Order or authorisation of, or registration, declaration or filing with, or notice to, any Governmental Entity, is required by or with respect to such RU Shareholder in connection with the execution and delivery of this Agreement by such RU Shareholder or the consummation by such RU Shareholder of the Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.3** **Litigation** 

There is no suit, action or proceeding or investigation pending or, to the Knowledge of such RU Shareholder, threatened against or affecting such RU Shareholder that, individually or in the aggregate, could reasonably be expected to prevent, hinder or materially delay the ability of such RU Shareholder to consummate the Transaction, nor is there any judgment, decree, injunction, rule or Order of any Governmental Entity outstanding against such RU Shareholder having any such effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.4** **Accredited Investor** 

Such RU Shareholder is an "accredited investor" as defined in Regulation D promulgated by the SEC under the Securities Act (which definition is set out in Annex 4 to this Agreement). Such RU Shareholder is knowledgeable about the industry in which the Company operates and is informed as to the risks of entering into the Transaction Documents.

**ARTICLE III**

3. **REPRESENTATIONS AND WARRANTIES IN RESPECT OF ROYAL URANIUM** 

Each of the Representative Shareholders jointly and severally represent and warrant to the Company that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.1** **Organisation, Standing and Corporate Power** 

Each member of the Royal Uranium Group (provided that to the extent this representation and warranty pertains to 2681911 Alberta Ltd., such representation and warranty is qualified by the Knowledge of the RU Representative Shareholders):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) is
 duly organised, validly existing and in good standing under the Laws of the Province of British
 Columbia, Canada, and has the requisite corporate power and authority and all government
 licenses, authorisations, Permits, consents and approvals required to own its assets and
 carry on its business as now being conducted, except where the failure to have such government
 licenses, authorisations, Permits, consents or approvals would not reasonably be expected
 to have a Material Adverse Effect; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) is
 duly qualified or licensed to do business and is in good standing in each jurisdiction in
 which the nature of its business or the ownership or leasing of its properties makes such
 qualification or licensing necessary, except where the failure to be so registered or in
 good standing would not reasonably be expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.2** **Subsidiaries** 

Royal Uranium does not own directly or indirectly, any equity or ownership interest in any other company, corporation, partnership, joint venture or otherwise, other than its three wholly-owned subsidiaries: 1382907 B.C. Ltd.; 2681911 Alberta Ltd. and 1000871349 Ontario Inc., and one wholly-owned subsidiary, the shares of which are in the process of being released from a share pledge agreement: 1485568 B.C. Ltd. (the "**Subsidiaries**"). Royal Uranium and the Subsidiaries are together referred to as the "**Royal Uranium Group**".

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.3** **Capital Structure of Royal Uranium** 

Royal Uranium has an unlimited number of common shares authorised and 78,581,029 common shares will be issued and outstanding as at the Closing Date. Agreement. All issued and outstanding shares in the capital of Royal Uranium are duly authorised, validly issued, fully paid and non-assessable and not subject to pre-emptive rights. There are no outstanding bonds, debentures, notes or other indebtedness or other securities of Royal Uranium. Except with respect to 1485568 B.C. Ltd., 100% of the shares in the Subsidiaries are owned by Royal Uranium; the shares of 1485568 B.C. Ltd. are in the process of being released from a share pledge agreement. To the extent that any of the Royal Uranium Shares have not yet been issued as at the date of this Agreement, the Representative Shareholders shall procure that Royal Uranium shall allot and issue such Royal Uranium prior to completion of the Transaction, such that those Royal Uranium Shares will form part of the Royal Uranium Shares to be acquired by the Company on Completion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.4** **Corporate Authority; Noncontravention** 

Royal Uranium has all requisite corporate and other power and authority to consummate the Transaction. The consummation by Royal Uranium of the Transaction has been (or at Closing will have been) duly authorised by all necessary corporate action on the part of Royal Uranium. The consummation of the Share Exchange will not, conflict with, or result in any breach or violation of, or Default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of or "put" right with respect to any obligation or to a loss of a material benefit under, or result in the creation of any Lien upon any of the properties or Assets of Royal Uranium or any member of the Royal Uranium Group (provided that to the extent this representation and warranty pertains to: (a) 2681911 Alberta Ltd., such representation and warranty is qualified by the Knowledge of the RU Representative Shareholders; and (b) 1485568 B.C. Ltd. such representation and warranty is qualified by the fact that the shares of 1485568 B.C. Ltd. are in the process of being released from a share pledge agreement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.5** **Governmental Authorisation** 

No consent, approval, Order or authorisation of, or registration, declaration or filing with, or notice to, any Governmental Entity in Canada, is required by or with respect to any member of the Royal Uranium Group (provided that to the extent this representation and warranty pertains to 2681911 Alberta Ltd., such representation and warranty is qualified by the Knowledge of the RU Representative Shareholders) in connection with the consummation by Royal Uranium of the Transaction, except where the failure to obtain such consent, approval, Order or authorisation, or obtain or make such registration, declaration, filing or notice, would not reasonably be expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.6** **Litigation; Compliance with Laws** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) There
 is no suit, action or proceeding or investigation pending or, to the Knowledge of the Representative
 Shareholders, threatened against or affecting any member of the Royal Uranium Group, that,
 individually or in the aggregate, could reasonably be expected to have a Material Adverse
 Effect with respect to the Royal Uranium Group nor is there any judgment, decree, injunction,
 rule or Order of any Governmental Entity outstanding against any member of the Royal Uranium
 Group having any such effect. No member of the Royal Uranium Group (provided that to the
 extent this representation and warranty pertains to 2681911 Alberta Ltd., such representation
 and warranty is qualified by the Knowledge of the RU Representative Shareholders) nor, to
 the Knowledge of the Representative Shareholders, any director or officer of any member of
 the Royal Uranium Group, is or has been the subject of any Order involving a violation of
 or liability under federal or state securities laws or a breach of fiduciary duty.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 conduct of the business of the Royal Uranium Group (provided that to the extent this representation
 and warranty pertains to 2681911 Alberta Ltd., such representation and warranty is qualified
 by the Knowledge of the RU Representative Shareholders) complies with all statutes, Laws,
 regulations, ordinances, rules, judgments, Orders, decrees or arbitration awards applicable
 thereto, except where such non-compliance would not reasonably be expected to have a Material
 Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.7** **Filings; Financial Statements** 

Each member of the Royal Uranium Group (provided that to the extent this representation and warranty pertains to 2681911 Alberta Ltd., such representation and warranty is qualified by the Knowledge of the RU Representative Shareholders) has made all filings, returns and submitted all other documents as are required by Law to be filed with a Governmental Authority in Canada, except: (a) with respect to the annual Tax Returns for 2024, the preparation and filing of which are in process; or (b) where the failure to make filings, returns or submissions would not reasonably be expected to have a Material Adverse Effect. As of their respective dates or if amended, as of the dates of the amendments, the financial statements of Royal Uranium complied as to form in all material respects with applicable accounting requirements and the published rules and regulations applicable thereto. Such financial statements have been prepared, in all material respects, in accordance with IFRS, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial position of Royal Uranium as of the dates thereof and the consolidated results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.8** **Tax Returns and Tax Payments** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each
 member of the Royal Uranium Group (provided that to the extent this representation and warranty
 pertains to 2681911 Alberta Ltd., such representation and warranty is qualified by the Knowledge
 of the RU Representative Shareholders) has filed with the appropriate taxing authorities
 any Tax Returns required to be filed by it (taking into account all applicable extensions),
 other than with respect to the annual Tax Returns for 2024, the preparation and filing of
 which are in process. To the Knowledge of the Representative Shareholders, no member of the
 Royal Uranium Group has received a claim in writing by a taxing authority in a jurisdiction
 where such member of the Royal Uranium does not file Tax Returns that it is or may be subject
 to taxation by that jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) No
 material claim for unpaid Taxes has been received by any member of the Royal Uranium Group
 (provided that to the extent this representation and warranty pertains to 2681911 Alberta
 Ltd., such representation and warranty is qualified by the Knowledge of the RU Representative
 Shareholders) or become a Lien against the property of any member of the Royal Uranium Group
 or, to the Knowledge of the Representative Shareholders, is being asserted against any member
 of the Royal Uranium Group.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) As
 used herein, "Taxes" shall mean all taxes of any kind, including, without limitation,
 those on or measured by or referred to as income, gross receipts, sales, use, ad valorem,
 franchise, profits, license, withholding, payroll, employment, excise, severance, stamp,
 occupation, premium, value added, property or windfall profits taxes, customs, duties or
 similar fees, assessments or charges of any kind whatsoever, together with any interest and
 any penalties, additions to tax or additional amounts imposed by any Governmental Authority,
 domestic or foreign. As used herein, "Tax Return" shall mean any return, report
 or statement required to be filed (and due to be filed) with any Governmental Authority with
 respect to Taxes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.9** **Royal Uranium Royalty Agreements** 

Royal Uranium (or a member of the Royal Uranium Group) is party to the Royal Uranium Royalty Agreements and such agreements are, as at the date of this Agreement (which shall be deemed to be repeated at Closing by reference to the position as at the date of Closing), to the Knowledge of the Representative Shareholders (other than in respect of the royalty interests acquired from Altius Royalty Corporation which were acquired on an "as is" basis and accordingly, the foregoing representation and warranty is limited thereby), in full force and effect and have been validly executed by Royal Uranium (or a member of the Royal Uranium Group), and to the Knowledge of the Representative Shareholders (other than in respect of the royalty interests acquired from Altius Royalty Corporation which were acquired on an "as is" basis and accordingly, the foregoing representation and warranty is limited thereby), all other parties thereto. Royal Uranium shall, and the Representative Shareholders shall procure that Royal Uranium shall, take all commercially reasonable efforts to preserve intact such agreements for the period up to and including to the Closing Date such that the Royal Uranium Royalty Agreements shall remain in full force and effect, to the Knowledge of the Representative Shareholders (other than in respect of the royalty interests acquired from Altius Royalty Corporation which were acquired on an "as is" basis and accordingly, the foregoing representation and warranty is limited thereby), as at the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.10** **Full Disclosure** 

Each of the representations and warranties made by the Representative Shareholders in this Agreement (taking into account any Knowledge, materiality and/or Material Adverse Effect contained therein), and, to the knowledge of the Representative Shareholders, all statements set forth in the certificates delivered by the Representative Shareholders on Closing pursuant to this Agreement, are true, correct and complete in all material respects do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make such representations, warranties or statements, in light of the circumstances under which they were made, misleading.

**ARTICLE IV**

4. **REPRESENTATIONS AND WARRANTIES IN RESPECT OF THE COMPANY** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 **Organisation, Standing and Corporate Power** 

The Company is duly organised, validly existing and in good standing under the Laws of Ireland and has the requisite corporate power and authority and all government licenses, authorisations, Permits, consents and approvals required to own its assets and carry on its business as now being conducted, except where the failure to have such government licenses, authorisations, Permits, consents and approvals would not reasonably be expected to have a Material Adverse Effect. The Company is duly qualified or licensed to do business and is in good standing in each jurisdiction in which the nature of its business or the ownership or leasing of its properties makes such qualification or licensing necessary, except where the failure to be so registered or in good standing would not reasonably be expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.2** **Capital Structure of the Company** 

The Company has an authorised share capital of USD 351,212.50 divided into 100,000,000 A Ordinary Shares; 2,125,000 B Ordinary Shares; 10,000,000 preferred shares and 25,000 deferred ordinary shares. As of February 11, 2026, the Company has 2,345,718 ordinary shares issued and outstanding (which number may increase between the date of this Agreement and Closing by virtue of any further investment that may be made in the Company during that period). All outstanding shares in the capital of the Company are duly authorised, validly issued, fully paid and non-assessable and not subject to pre-emptive rights. The HTOO Shares issuable in connection with the Share Exchange will be duly authorised, validly issued, fully paid and non-assessable and not subject to pre-emptive rights or Liens (other than the restrictions provided at Section 7 of this Agreement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.3** **Corporate Authority; Noncontravention** 

The Company has all requisite corporate and other power and authority to enter into this Agreement and to consummate the Transaction. The execution and delivery of this Agreement by the Company and the consummation by the Company of the Transaction have been (or at Closing will have been) duly authorised by all necessary corporate action on the part of the Company. This Agreement has been duly executed and when delivered by the Company shall constitute valid and binding obligations of the Company, enforceable against the Company in accordance with its terms, except as such enforcement may be limited by bankruptcy, insolvency or other similar Laws affecting the enforcement of creditors' rights generally or by general principles of equity. The execution and delivery of this Agreement does not, and the consummation of the Share Exchange and compliance with the provisions hereof will not, conflict with, or result in any breach or violation of, or Default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of or "put" right with respect to any obligation or to a loss of a material benefit under, or result in the creation of any Lien upon any of the properties or Assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.4** **Governmental Authorisation** 

No consent, approval, Order or authorisation of, or registration, declaration or filing with, or notice to, any Governmental Entity, is required by or with respect to the Company in connection with the execution and delivery of this Agreement by the Company or the consummation by the Company of the Transaction, other than shareholder approval and such notifications, filings and approvals as are required under the Irish Takeover Panel Act 1997, Takeover Rules, 2022 (the "**Takeover Rules**"), which approvals and necessary consents shall be obtained by the Company on or prior to the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.5** **Litigation; Compliance with Laws** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) There
 is no suit, action or proceeding or investigation pending or, to the Knowledge of the Company,
 threatened against or affecting the Company, that, individually or in the aggregate, could
 reasonably be expected to have a Material Adverse Effect with respect to the Company nor
 is there any judgment, decree, injunction, rule or Order of any Governmental Entity outstanding
 against the Company having any such effect. Neither the Company nor, to the Knowledge of
 the Company, any director or officer of the Company, is or has been the subject of any Order
 involving a violation of or liability under federal or state securities laws or a breach
 of fiduciary duty.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 conduct of the business of the Company complies with all statutes, Laws, regulations, ordinances,
 rules, judgments, Orders, decrees or arbitration awards applicable thereto, except where
 such non-compliance would not reasonably be expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.6** **Filings; Financial Statements** 

The Company has filed all reports, schedules, forms, statements and other documents required by Law to be filed by it with the SEC (the "**Company Documents**"). As of their respective dates or if amended, as of the dates of the amendments, the Company Documents complied in all material respects with the requirements of the rules and regulations applicable to the Company Documents, and none of the Company Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of their respective dates or if amended, as of the dates of the amendments, the financial statements of the Company included in the Company Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations applicable thereto. Such financial statements have been prepared in accordance with IFRS, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.7** **Tax Returns and Tax Payments** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Company has filed with the appropriate taxing authorities any Tax Returns required to be
 filed by it (taking into account all applicable extensions). To the Knowledge of the Company,
 the Company has not received a claim in writing by a taxing authority in a jurisdiction where
 the Company does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) No
 material claim for unpaid Taxes has been received by the Company or become a Lien against
 the property of the Company or, to the Knowledge of the Company, is being asserted against
 the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.8** **Full Disclosure** 

All of the representations and warranties made by the Company in this Agreement, and all statements set forth in the certificates delivered by the Company on Closing pursuant to this Agreement, are true, correct and complete in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make such representations, warranties or statements, in light of the circumstances under which they were made, misleading.

**ARTICLE V**

5. **COVENANTS OF THE PARTIES** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1** **Conduct of Royal Uranium Business** 

From the date of this Agreement and until the Closing Date, or until the prior termination of this Agreement, the Representative Shareholders shall use commercially reasonable efforts to procure that no member of the Royal Uranium Group shall, unless agreed to in writing by the Company:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) engage
 in any transaction or create or suffer to exist any Lien or other encumbrance upon any of
 its assets which will not be discharged in full prior to the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) allot,
 issue or grant any shares or other equity interests or securities or any interest or right
 capable of being converted into shares or equity interests in the capital of Royal Uranium,
 other than as set forth in Section 3.3;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) sell,
 assign or otherwise transfer any of its assets, or cancel or compromise any debts or claims
 related to its assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) fail
 to use reasonable efforts to preserve intact its present business organisations and preserve
 its material relationships with counterparties to the Royal Uranium Royalty Agreements and
 others, to the end that its good will and ongoing business not be impaired prior to the Closing
 Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) terminate
 or permit to be terminated or permit to lapse any of the Royal Uranium Royalty Agreements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) intentionally
 permit any Material Adverse Effect to occur with respect to Royal Uranium;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) make
 any material change in its accounting or bookkeeping methods, principles or practices, except
 as required by IFRS; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) authorise
 any, or commit or agree to take any of, the foregoing actions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.2** **Conduct of Company Business** 

From the date of this Agreement and until the Closing Date, or until the prior termination of this Agreement, the Company shall not, unless agreed to in writing by the Representative Shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) sell,
 assign or otherwise transfer any material assets, or cancel or compromise any material debts
 or claims related to its assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) fail
 to use reasonable efforts to preserve intact its present business organisations and preserve
 its material relationships with counterparties to its material Contracts and others, to the
 end that its good will and ongoing business not be impaired prior to the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) terminate
 or permit to be terminated or permit to lapse any of the material Contracts of the Company
 (save where such Contract terminates by reason of its stated term expiring);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) intentionally
 permit any Material Adverse Effect to occur with respect to the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) make
 any material change in its accounting or bookkeeping methods, principles or practices, except
 as required by IFRS; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) authorise
 any, or commit or agree to take any of, the foregoing actions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.3** **Satisfaction of Conditions Precedent** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) From
 and after the date of this Agreement until the earlier of the Closing Date or the termination
 of this Agreement in accordance with its terms, the Representative Shareholders will use
 their commercially reasonable efforts to satisfy or cause to be satisfied all the conditions
 precedent that are set forth in Section 6.1 and 6.2, and each of the RU Shareholders agree,
 on a several basis (and not joint), to use their commercially reasonable efforts to cause
 the Transaction to be consummated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) From
 and after the date of this Agreement until the earlier of the Closing Date or the termination
 of this Agreement in accordance with its terms, the Company will use its commercially reasonable
 efforts to satisfy or cause to be satisfied all the conditions precedent that are set forth
 in Section 6.1 and 6.3, and the Company will use its commercially reasonable efforts to cause
 their actions and obligations in respect of the Transaction to be consummated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.4** **No Other Negotiations** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) As
 of the date of this Agreement, neither Royal Uranium nor the Company has entered into any
 agreement or understanding with, nor are they engaging in any discussions with any third
 party concerning a sale of substantially all of the assets or capital stock of Royal Uranium
 or the Company, as applicable, to another acquirer ()"**Alternative Acquisition** ")
 including, without limitation, any agreement or understanding that would require the Company
 or Royal Uranium, as applicable, to notify any third party of the terms of this Agreement.
 From and after the date of this Agreement until the earlier of the Closing Date or the termination
 of this Agreement in accordance with its terms, neither the Company nor Royal Uranium shall,
 directly or indirectly, (a) initiate, solicit, encourage, negotiate, accept or discuss any
 transaction or series of transactions with any Person, other than the Company or Royal Uranium,
 as applicable, and its Affiliates involving any Alternative Acquisition, (b) provide information
 with respect to a party to any Person, other than in connection with this Agreement, relating
 to a possible Alternative Acquisition by any Person, (c) enter into an agreement with any
 Person providing for a possible Alternative Acquisition, or (d) make or authorise any statement,
 recommendation or solicitation in support of any possible Alternative Acquisition by any
 Person, other than by Company or Royal Uranium, as applicable, and its Affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) As
 of the date of this Agreement, each RU Shareholder agrees, on a several basis (and not joint),
 that such RU Shareholder has not entered into any agreement or understanding with, nor are
 they engaging in any discussions with any third party concerning an Alternative Acquisition,
 including, without limitation, any agreement or understanding that would require the Company
 to notify any third party of the terms of this Agreement. From and after the date of this
 Agreement until the earlier of the Closing Date or the termination of this Agreement in accordance
 with its terms, such RU Shareholder shall not, directly or indirectly, (a) initiate, solicit,
 encourage, negotiate, accept or discuss any transaction or series of transactions with any
 Person, other than the Company and its Affiliates involving any Alternative Acquisition,
 (b) provide information with respect to any party to any Person, other than in connection
 with this Agreement, relating to a possible Alternative Acquisition by any Person, (c) enter
 into an agreement with any Person providing for a possible Alternative Acquisition, or (d)
 make or authorise any statement, recommendation or solicitation in support of any possible
 Alternative Acquisition by any Person, other than by Company and its Affiliates.

If any party receives any unsolicited offer, inquiry or proposal to enter into discussions or negotiations relating to an Alternative Acquisition, or that could reasonably be expected to lead to an Alternative Acquisition, or any request for non-public information relating to Royal Uranium or the Company (other than from a respective representative), such party shall promptly notify the other parties thereof, including information as to the identity of the party making any such offer, inquiry or proposal and the specific terms of such offer, inquiry or proposal, as the case may be, and shall keep the parties promptly informed of any developments with respect to same.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.5** **Access** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Subject
 to any confidentiality obligations to which Royal Uranium is subject and save for any documents
 to which legal privilege applies, the Representative Shareholders shall afford to the Company,
 and to the officers, employees, accountants, counsel, financial advisors and other representatives
 of Company, reasonable access during normal business hours during the period prior to the
 Closing Date or the earlier termination of this Agreement, to Royal Uranium's assets,
 books, contracts, commitments, personnel and records in the possession of Royal Uranium and,
 during such period, the Representative Shareholders shall furnish promptly to the Company,
 (a) a copy of each material report, schedule, and other documents filed by it during such
 period with a Governmental Authority pursuant to the requirements of federal or state Laws
 and (b) such other information concerning its business, properties and personnel as the Company
 or its representatives may reasonably request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Subject
 to any confidentiality obligations to which the Company is subject and save for any documents
 to which legal privilege applies, the Company shall afford to Royal Uranium, and to the officers,
 employees, accountants, counsel, financial advisors and other representatives of Royal Uranium,
 reasonable access during normal business hours during the period prior to the Closing Date
 or the earlier termination of this Agreement, to the Company's assets, books, contracts,
 commitments, personnel and records in the possession of the Company and, during such period,
 the Company shall furnish promptly to Royal Uranium, (a) a copy of each material report,
 schedule, and other documents filed by it during such period with a Governmental Authority
 pursuant to the requirements of federal or state Laws and (b) such other information concerning
 its business, properties and personnel as Royal Uranium or its representatives may reasonably
 request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.6** **Notification regarding Representations and Warranties and Covenants** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Representative Shareholders shall give prompt notice to Company of: (i) the occurrence or
 non-occurrence of any event the occurrence or non-occurrence of which would cause any Royal
 Uranium representation or warranty contained in this Agreement to be untrue or inaccurate
 in any material respect at or prior to the Closing Date; and, (ii) any failure of Royal Uranium
 to comply in all material respects with or satisfy any covenant, condition or agreement to
 be complied with or satisfied by it hereunder; provided, however, that the delivery of any
 notice pursuant to this section shall not limit or otherwise affect the remedies available
 hereunder to Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each
 RU Shareholder shall on a several basis (and not joint), give prompt notice to Company of:
 (i) the occurrence or non-occurrence of any event the occurrence or non-occurrence of which
 would cause any of such RU Shareholder's representations or warranties contained in
 this Agreement to be untrue or inaccurate in any material respect at or prior to the Closing
 Date; and, (ii) any failure of such RU Shareholder to comply in all material respects with
 or satisfy any covenant, condition or agreement to be complied with or satisfied by such
 RU Shareholder hereunder; provided, however, that the delivery of any notice pursuant to
 this section shall not limit or otherwise affect the remedies available hereunder to Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Company shall give prompt notice to Royal Uranium of: (i) the occurrence or non-occurrence
 of any event the occurrence or non-occurrence of which would cause any Company representation
 or warranty contained in this Agreement to be untrue or inaccurate in any material respect
 at or prior to the Closing Date; and, (ii) any failure of the Company to comply in all material
 respects with or satisfy any covenant, condition or agreement to be complied with or satisfied
 by it hereunder; provided, however, that the delivery of any notice pursuant to this section
 shall not limit or otherwise affect the remedies available hereunder to Royal Uranium or
 the RU Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.7** **Covenant of the Company regarding Shareholder Approval** 

Following execution of this Agreement and in accordance with the Company's obligations on Closing as set out in section 6.2(b) below, the Company shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) prepare
 a draft circular to shareholders of the Company containing notice of the EGM and such information
 regarding the Transaction as is required by the Takeover Rules (the "**Circular** ")
 and furnish a draft of such Circular to the Representative Shareholders for review within
 5 Business Days of the date of this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) within
 3 Business Days of receipt of reasonably satisfactory input from the Representative Shareholders,
 submit the draft Circular to the Irish Takeover Panel for review;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) within
 5 Business Days of the Irish Takeover Panel providing its confirmation that the Circular
 satisfies the necessary requirements under the Takeover Rules, commence the mailing to shareholders
 providing 21 clear days' notice of the extraordinary general meeting of the shareholders
 of the Company (the "**EGM** ").

The Company shall use all reasonable endeavours to procure that the EGM is held, and shareholder approval of the Transaction is obtained (including, without limitation, by including in the Circular a recommendation to vote in favour of the Transaction and a statement that all directors and officers of the Company have agreed to so vote in favour), as soon as reasonably practicable following the date of this Agreement. The Company shall keep the Representative Shareholders reasonably informed of progress in relation to the preparation of the Circular and the convening of the EGM.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.8** **Notices of Certain Events** 

The Representative Shareholders and Company shall promptly notify each other of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any
 notice or other communication from any Person alleging that the consent of such Person is
 or may be required in connection with the Transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any
 notice or other communication from any Governmental Entity in connection with the Transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any
 actions, suits, claims, investigations or proceedings commenced or, to its Knowledge, threatened
 against, relating to or involving or otherwise affecting such party that, if pending on the
 date of this Agreement, would, in the case of the Representative Shareholders, have been
 required to be disclosed by the Representative Shareholders pursuant to Section 3, or in
 the case of the Company, have been required to be disclosed pursuant to Section 4. Delivery
 of notice pursuant to this section shall not limit or otherwise affect remedies available
 to any party hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.9** **Public Announcements** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) No
 party shall have the right to issue any press release or other public statement with respect
 to this Agreement or the transactions contemplated herein without the prior written consent
 of each other party (not to be unreasonably withheld, delayed, denied or conditioned), except
 as permitted by this Section 5.9. This does not preclude appropriate announcements by the
 Company after the closing of the Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 foregoing clause 5.9(a) shall not prohibit (i) any disclosure of the identities of the RU
 Shareholders in the circular to be issued to the shareholders of the Company following the
 date of this Agreement, or (ii) any disclosure of any information relating to any or all
 of the Transaction, the Royal Uranium Group and/or any RU Shareholder, that is required,
 on advice of counsel, to be made to the Irish Takeover Panel or any other Irish regulatory
 authority or statutory body, provided that in each case the disclosing party shall, to the
 extent reasonably practicable and permitted by Law, provide advance notice to the other parties
 of any such required disclosure and cooperate in good faith to minimize the extent of such
 disclosure and provided further that such disclosure is limited to such information as is
 strictly required to be so disclosed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding
 clause 5.9(a), any disclosure of any information relating to this Agreement, any RU Shareholder
 (including but not limited to the name(s) of any RU Shareholder), the Company, Royal Uranium,
 the Transaction, any of the Transaction Documents, or any other matter related thereto, shall
 be made (i) to the extent required, on advice of counsel, by applicable U.S. federal or state
 securities laws, including the Securities Act and the Securities Exchange Act of 1934, as
 amended, or any rules or regulations promulgated thereunder by the SEC, including any filings
 required to be made with the SEC by the Company, any RU Shareholder, or any of their respective
 Affiliates (including, without limitation, filings on Schedule 13D, Schedule 13G, Form 3,
 Form 4, Form 5, Form 8-K, Form 6-K, Form 20-F or any proxy statement or registration statement)
 (and provided that such disclosure is limited to such information as is strictly required
 to be so disclosed), (ii) to the extent required, on advice of counsel, by any stock exchange
 or trading market on which a party's securities are listed or traded, or (iii) to,
 on advice of counsel any Governmental Entity where such disclosure is required by Law, provided
 that in each case the disclosing party shall, to the extent reasonably practicable and permitted
 by Law, provide advance notice to the other parties of any such required disclosure and cooperate
 in good faith to minimize the extent of such disclosure and provided further that such disclosure
 is limited to such information as is strictly required to be so disclosed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.10** **Transfer Taxes** 

The Company and the Representative Shareholders shall cooperate in the preparation, execution and filing of all returns, questionnaires, applications or other documents regarding any real property transfer or gains, sales, use, transfer, value added, stock transfer and stamp taxes, any transfer, recording, registration and other fees, and any similar taxes which become payable in connection with the transactions contemplated hereby that are required or permitted to be filed on or before the Closing Date. All parties agree that the Company will pay any real property, transfer or gains tax, stamp tax, stock transfer tax, or other similar tax imposed on the transactions contemplated by this Agreement (collectively, "**Transfer Taxes**"). The Representative Shareholders shall cooperate with Company in the filing of any returns with respect to the Transfer Taxes to the extent reasonably requested by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.11** **Reasonable Efforts** 

The Company and the Representative Shareholders further agree to use commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable to consummate and make effective, and to satisfy all conditions to, in the most expeditious manner practicable, the transactions contemplated by this Agreement, including (i) the obtaining of all other necessary actions or nonactions, waivers, consents, licenses, Permits, authorisations, Orders and approvals from Governmental Entities and the making of all other necessary registrations and filings required in order to consummate the Transaction, (ii) the obtaining of all consents, approvals or waivers from third parties required in connection with the Transaction, (iii) the satisfaction of all conditions precedent to the parties' obligations hereunder, and (iv) the execution and delivery of any additional instruments necessary to consummate the Transaction, and to fully carry out the purposes of, this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.12** **Fees and Expenses** 

Each party will be responsible for all of the legal, accounting and other expenses incurred by such party hereto in connection with the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.13** **Regulatory Matters and Approvals** 

The Representative Shareholders and the Company will give any notices to, make any filings with, and use its commercially reasonable efforts to obtain any authorisations, consents, and approvals of Governmental Entities required in connection with the consummation of the Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.14** **Post-Closing Covenants** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Representative Shareholders shall use commercially reasonable efforts to support the Company
 and its representatives in the timely completion and filing by the Company of the Resale
 Registration Statement with the SEC in respect of the HTOO Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Company shall file a Resale Registration Statement in respect of the relevant HTOO Shares
 as soon as practicable and in any event within twenty (20) Business Days of expiry of the
 restrictions under Section 7.

**ARTICLE VI**

6. **CONDITIONS TO CLOSING** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.1** **Condition to Obligation of Each Party to Effect the Share Exchange** 

The respective obligations of Company and the RU Shareholders to consummate the transactions contemplated herein are subject to the satisfaction or waiver in writing at or prior to the Closing Date of the following conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **No Injunctions** 

No temporary restraining Order, preliminary or permanent injunction issued by any court of competent jurisdiction preventing or prohibiting the consummation of the Transaction shall be in effect; provided, however, that each of Company and the Representative Shareholders shall have used its commercially reasonable efforts to prevent the entry of such Orders or injunctions and to appeal as promptly as possible any such Orders or injunctions that may be entered.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.2** **Additional Conditions to Obligations of Company** 

The obligations of Company to consummate the Transaction are also subject to the satisfaction or (save where required by Law) waiver in writing at or prior to the Closing Date of the following conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **RU Shareholder Joinder** 

Such RU Shareholders that have not signed this Agreement shall have executed a joinder to this Agreement in a form attached as Annex 3 to this Agreement, such that the RU Shareholders that have signed this Agreement and those that have executed the aforementioned joinder shall together hold not less than 75% of the issued shares in Royal Uranium immediately prior to completion of the Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Company Shareholder Approval** 

The Company shall have obtained the requisite shareholder approval as required by the Takeover Rules.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **Representations and Warranties** 

The representations and warranties of the RU Shareholders and the Representative Shareholders contained in this Agreement and in any certificate or other writing delivered to Company pursuant hereto shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of the Closing Date (except if made as of a specified date, in which case such representation and warranty shall be true and correct in all material respects as of such date), and Company shall have received a certificate to such effect signed by the Representative Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) **Agreements and Covenants** 

Royal Uranium and the RU Shareholders shall have performed or complied in all material respects with all agreements and covenants required by this Agreement to be performed or complied with by them on or prior to the Closing Date, and Company shall have received a certificate to such effect signed by the Representative Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) **Consents Obtained** 

All consents, waivers, approvals, authorisations or Orders required to be obtained, and all filings required to be made, by Royal Uranium or the RU Shareholders for the authorisation, execution and delivery of this Agreement and the consummation by it of Transaction shall have been obtained and made by Royal Uranium or the RU Shareholders (as applicable).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) **Absence of Material Adverse Effect** 

Since the date of this Agreement, there shall not have been any Material Adverse Effect on Royal Uranium.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) **Share Capital of Royal Uranium** 

The share capital of Royal Uranium as at immediately prior to Closing shall be as set out in Annex 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.3** **Additional Conditions to Obligations of RU Shareholders** 

The obligations of the RU Shareholders to consummate the Transaction are also subject to the satisfaction or (save where required by Law) waiver in writing at or prior to the Closing Date of the following conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Shareholder Approval** 

The Company shall have obtained the requisite shareholder approval as required by the Irish Takeover Panel Act 1997, Takeover Rules.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Representations and Warranties** 

The representations and warranties of the Company contained in this Agreement and in any certificate or other writing delivered to the Shareholder Representatives pursuant hereto shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of the Closing Date (except if made as of a specified date, in which case such representation and warranty shall be true and correct in all material respects as of such date), and the Representative Shareholders shall have received a certificate to such effect signed by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **Agreements and Covenants** 

Company shall have performed or complied, in all material respects, with all agreements and covenants required by this Agreement to be performed or complied with by it on or prior to the Closing Date, and the Representative Shareholders shall have received a certificate to such effect signed by the Chief Executive Officer of Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) **Consents Obtained** 

All consents, waivers, approvals, authorisations or Orders required to be obtained, and all filings required to be made, by Company for the authorisation, execution and delivery of this Agreement and the consummation by it of the Transaction shall have been obtained and made by Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) **Absence of Material Adverse Effect** 

Since the date of this Agreement, there shall not have been any Material Adverse Effect on the Company.

**ARTICLE VII**

7. **Lock-up** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.1** During
 the period commencing on the date of this Agreement and ending on the date that is six (6)
 months after such date, no RU Shareholder shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Transfer
 any HTOO Shares held by such RU Shareholder (collectively, the "**Lock-Up Securities** "),
 where "Transfer" means offer, sell, contract to sell, lend, hypothecate, pledge
 or otherwise dispose of (or enter into any transaction which is designed to), or might reasonably
 be expected to, result in the disposition, whether by actual disposition or effective economic
 disposition due to cash settlement or otherwise, by such RU Shareholder, directly or indirectly;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) enter
 into any short sale or any purchase, sale or grant of any right (including, without limitation,
 any put or call option) with respect to any security (other than a broad-based market basket
 or index) that includes, relates to or derives any significant part of its value from the
 Lock-Up Securities or any other agreement that transfers, in whole or in part, any of the
 economic consequences of ownership of any Lock-Up Securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) grant
 any proxies or powers of attorney with respect to any Lock-Up Securities, deposit any Lock-Up
 Securities into a voting trust, or enter into a voting agreement or similar arrangement or
 commitment with respect to any Lock-Up Securities, save for the grant of proxies in the ordinary
 course to management or other nominees in connection with shareholder meetings; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) make
 any offer or enter into any agreement or binding arrangement or commitment providing for
 any of the foregoing actions in clauses (a) to (c), or publicly disclose the intention to
 take any of the foregoing actions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.2** Each
 RU Shareholder (or any RU Shareholders who are Affiliates) who, pursuant to this Agreement,
 is (or are together) issued more than 25,000 HTOO Shares (as set out in Annex 2), shall be
 subject to the restrictions set out in Section 7.1:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) for
 a period of six (6) months from the date of this Agreement in respect of 100% of the HTOO
 Shares issued to them pursuant to this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) for
 a period of twelve (12) months from the date of this Agreement in respect of two thirds of
 the HTOO Shares issued to them pursuant to this Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) for
 a period of eighteen (18) months from the date of this Agreement in respect of one third
 of the HTOO Shares issued to them pursuant to this Agreement (such that such RU Shareholder
 shall be fully released from the restrictions set out in Section 7.1 after the expiry of
 eighteen (18) months following the date of this Agreement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.3** Each
 RU Shareholder who, together with its Affiliates, pursuant to this Agreement is issued 25,000
 HTOO Shares or fewer (as set out in Annex 2) shall be fully released from the restrictions
 set out in Section 7.1 after the expiry of six (6) months following the date of this Agreement.

8. **INDEMNIFICATION OF DIRECTORS AND OFFICERS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.1** The
 Company agrees that all rights to indemnification, exculpation, and advancement of expenses
 now existing in favour of the directors and officers of Royal Uranium, as provided in Royal
 Uranium's constating documents as of the date of this Agreement or otherwise in any
 written agreement with Royal Uranium in effect as of the date of this Agreement (or as of
 the Closing Date provided that the Company has provided its prior consent to the entry into
 any such agreement after the date of this Agreement) and made available to the Company with
 respect to any matters occurring prior to the Closing Date, shall survive the Closing and
 shall continue in full force and effect for a period of six years following the Closing.
 From and after the Closing Date, the Company shall cause Royal Uranium to perform and discharge
 the Royal Uranium's obligations to provide such indemnification, exculpation, and advancement
 of expenses. To the maximum extent permitted by Law, such indemnification shall be mandatory
 rather than permissive, and from and after the Closing Date, the Company shall cause Royal
 Uranium to advance expenses in connection with such indemnification as provided in Royal
 Uranium's constating documents or other applicable agreements as described above. The
 indemnification, liability limitation, exculpation, or advancement of expenses provisions
 of Royal Uranium's constating documents provided to the Company shall not be amended,
 repealed, or otherwise modified after the Closing Date in any manner that would adversely
 affect the rights thereunder of individuals who, as of the Closing Date or at any time prior
 to the Closing Date, were directors or officers of the Company, unless such modification
 is strictly required by Law.

**ARTICLE VIII**

9. **TERMINATION; SURVIVAL; LIMITATIONS OF LIABILITY** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.1** **Termination** 

This Agreement may be terminated at any time prior to the Closing Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) by
 mutual written agreement of the Representative Shareholders and Company duly authorised by
 the board of directors of Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) by
 either the Representative Shareholders or Company, if the other party has breached any representation,
 warranty, covenant or agreement of such other party set forth in this Agreement and such
 breach has resulted or can reasonably be expected to result in a Material Adverse Effect
 on such other party or would prevent or materially delay the consummation of the transactions
 contemplated by this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) by
 any party, if all the conditions to the obligations of such party for Closing the transactions
 contemplated by this Agreement shall not have been satisfied or waived on or before the Final
 Date (as defined below) other than as a result of a breach of this Agreement by the terminating
 party; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) by
 any party, if a permanent injunction or other Order by any Federal or state court which would
 make illegal or otherwise restrain or prohibit the consummation of the Transaction shall
 have been issued and shall have become final and non-appealable.

As used herein, the "**Final Date**" shall be the date falling 12 months from the date of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.2** **Notice of Termination** 

Any termination of this Agreement under Section 9.1 above will be effective immediately upon by the delivery of written notice of the terminating party to the other parties hereto specifying with reasonable particularity the reason for such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.3** **Effect of Termination** 

In the case of any termination of this Agreement as provided in this Section 9, this Agreement shall be of no further force and effect, and nothing herein shall relieve any party from liability for any prior breach of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.4** **Survival** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 representations and warranties in Section 2 and Section 4.3 and 4.4 shall survive for a period
 of 18 months post-Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 representations and warranties in Section 3 and Section 4.1, 4.2 and 4.5 to 4.9 shall survive
 for a period of six months post-Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.5** **Limitation of Liability** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) A
 party shall not be liable in respect of any claim for Losses under this Agreement to which
 any of the survival periods referred to in Section 9.4(a) or 9.4(b) apply unless a claim
 with respect to such Losses was notified in accordance with this Agreement before the end
 of the applicable survival period. The parties acknowledge and agree that any party may make
 a claim for damages for breach of contract in respect of any breach by the other party of
 this Agreement (including the representations and warranties made herein) and further acknowledge
 that, in the case of a breach of representation or warranty, damages will be assessed on
 the basis of a diminution in value of the assets acquired.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 RU Shareholders (and for greater certainty, all references to RU Shareholders refer to and
 include the Representative Shareholders acting in such representative capacity) shall have
 no liability to the Company for Losses to the extent that such Losses arise or increase as
 a direct result of: (i) any action or inaction by a RU Shareholder or Royal Uranium at the
 written direction or with the written consent of the Company; (ii) acts or things done or
 omitted to be done under and in accordance with the terms of any Transaction Document; (iii)
 any changes in circumstances or changes in the legal position, including changes/introduction
 of law, case law, new laws, rules, regulations, administrative practice of a government,
 governmental department, agency or regulatory bodies, or changes in interpretation of the
 same that may occur after the date of this Agreement or any change in the current published
 practice of any Tax, social security, regulatory or administrative authority made or entered
 into effect after the date of this Agreement; or (iv) voluntary acts or omission of the Company
 or its Affiliates (which term shall not include any of the RU Shareholders) after the date
 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Company shall have no liability to a RU Shareholder for Losses to the extent that such Losses
 arise or increase as a direct result of: (i) any action or inaction by the Company at the
 written direction or with the written consent of Royal Uranium or the RU Shareholder or a
 Representative Shareholders; (ii) acts or things done or omitted to be done under and in
 accordance with the terms of any Transaction Document; (iii) any changes in circumstances
 or changes in the legal position, including changes/introduction of law, case law, new laws,
 rules, regulations, administrative practice of a government, governmental department, agency
 or regulatory bodies, or changes in interpretation of the same that may occur after the date
 of this Agreement or any change in the current published practice of any Tax, social security,
 regulatory or administrative authority made or entered into effect after the date of this
 Agreement; or (iv) voluntary acts or omission of Royal Uranium or of such RU Shareholder
 (including the Representative Shareholders) after the date of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) A
 RU Shareholder shall have no liability and no obligation to make any payment to the Company,
 and the Company shall have no liability and no obligation to make any payment to the RU Shareholders,
 in respect of any claim for Losses for any breach of representation, warranty or covenant,
 unless the amount of Losses incurred by the Company or a RU Shareholder (as applicable) is
 at least:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) USD50,000,
 in respect a claim for Losses in connection with a breach of representation or warranty under
 Section 2, Section 4.2, 4.3 or 4.4; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) USD2,000,000,
 in respect of a claim for Losses in connection with a breach of representation or warranty
 under Section 3, Section 4.1or 4.5 to 4.8 or a breach of covenant,

(the "**Minimum Claim Threshold**"), in which case the RU Shareholder or the Company (as applicable) shall be liable for the entire amount of the Losses incurred in aggregate (and not merely the excess above the applicable Minimum Claim Threshold).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The
 amount of any Losses that a RU Shareholder shall be liable for shall be reduced to the extent
 that the Company, its Affiliates and/or each of their respective shareholders, officers,
 directors, employees and agents realizes any Tax benefit resulting from the event or circumstances
 giving rise to such Losses. The amount of any Losses that the Company shall be liable for
 shall be reduced to the extent that any RU Shareholder, its Affiliates and/or each of their
 respective shareholders, officers, directors, employees and agents realizes any Tax benefit
 resulting from the event or circumstances giving rise to such Losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) A
 RU Shareholder shall not be liable to the Company under this Agreement or otherwise pursuant
 to applicable Laws for any Losses sustained by the Company, directly or indirectly, resulting
 from or relating to, any inaccuracy in or breach of representation or warranty if the Company
 had knowledge of such inaccuracy or breach prior to the date of this Agreement (or, in respect
 of the representations and warranties deemed repeated at Closing by virtue of Section 6.2(c)),
 prior to Closing), nor shall a RU Shareholder liable for any claim if and to the extent that
 the fact, matter, event or circumstance giving rise to the claim was disclosed to the Company
 in the Royal Uranium Data Room. The Company shall not be liable to a RU Shareholder under
 this Agreement or otherwise pursuant to applicable Laws for any Losses sustained by such
 RU Shareholder, directly or indirectly, resulting from or relating to, any inaccuracy in
 or breach of representation or warranty if the RU Shareholder or a Representative Shareholder
 had knowledge of such inaccuracy or breach prior to the date of this Agreement (or, in respect
 of the representations and warranties deemed repeated at Closing by virtue of Section 6.3(b)),
 prior to Closing), nor shall the Company be liable for any claim if and to the extent that
 the fact, matter, event or circumstance giving rise to the claim was disclosed to the RU
 Shareholder or a Representative Shareholder or was otherwise disclosed in any public announcements
 made by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Notwithstanding
 any other provision in this Article 9, for the avoidance of doubt, in no event shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 aggregate liability of the RU Shareholders under or in connection with this Agreement exceed
 the value of the HTOO Shares issued to the RU Shareholders on the Closing Date by reference
 to the details set out in Annex 2 and in this Section 9.5 and with such value being calculated
 pursuant to Section 9.5(i) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the
 liability of a RU Shareholder or
 in connection with this Agreement exceed the lesser of (i) the value of the HTOO Shares issued
 to such RU Shareholder on the Closing Date by reference to the details set out in Annex 2
 and in this Section 9.5 and with such value being calculated pursuant to Section 9.5(i);
 and (ii) the RU Shareholder's pro rata portion of the Losses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the
 aggregate liability of the Company under or in connection with this Agreement exceed USD
 9,000,000.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Neither
 the RU Shareholders nor the Company will be liable in respect of a claim to the extent that
 the party remedies the breach within thirty (30) days following notification of that fact
 or circumstance by the Company or the Representative Shareholders (as applicable).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Each
 RU Shareholder shall be entitled to satisfy any claim under this Article 9, at such RU Shareholder's
 sole discretion (i) by surrender for cancellation of some or all HTOO Shares issued to such
 RU Shareholder on the Closing Date; and/or (ii) by making a direct cash payment to the Company.
 The Company shall be entitled to satisfy any claim under this Article 9 at the Company's
 sole discretion (i) by the allotment and issue of HTOO Shares and/or (ii) by making a direct
 cash payment to the RU Shareholders. For the purposes hereof, a HTOO Share shall be deemed
 to have a value equal to the volume weighted average closing price of the HTOO Shares on
 the stock exchange in North America upon which the HTOO Shares are listed, for the ten day
 period prior to the date of surrender or allotment of such HTOO Shares, if applicable; provided
 however that if a RU Shareholder satisfies any claims by surrendering for cancellation all
 HTOO Shares issued to such RU Shareholder on the Closing Date, such RU Shareholder shall
 have no further liability under this Article 9, provided always that, if a RU Shareholder
 disposes of any HTOO Shares following service of a Claim Notice by the Company but prior
 to such Claim being agreed or determined, such RU Shareholder shall remain liable for the
 value of the HTOO Shares so disposed (which shall be deemed to have a value as determined
 in accordance with the foregoing provisions of this Section 9.5(i)).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) **Save in the case of fraud, fraudulent misrepresentation or wilful misconduct, the Representative Shareholders shall have no liability to the RU Shareholders (or any of them) in relation to their acting as Representative Shareholders in connection with the transactions contemplated by this Agreement.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.6** **Claim Procedure** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 any Losses are suffered by or asserted against any person entitled to make a claim hereunder
 (a "**Claiming Party** "), the Claiming Party shall notify the other Party
 (the "**Responding Party**") in writing (the "**Claim Notice** ").
 Such notice shall specify:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 factual basis for the claim; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the
 amount of the claim, or, if an amount is not then determinable, an approximate and reasonable
 estimate of the potential amount of the claim (to the extent ascertainable).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Following
 receipt of a Claim Notice from a Claiming Party, the Responding Party shall have 30 days
 to make such investigation of the claim as the Responding Party considers necessary or desirable
 (subject to any business or operational limitations, any confidentiality obligations and
 the need to preserve legal privilege). For the purpose of such investigation, the Claiming
 Party shall make reasonably available to the Responding Party during normal business hours
 the information relied upon by the Claiming Party to substantiate the claim and the personnel
 of the Claiming Party with knowledge regarding the subject matter of the claim. If the Claiming
 Party and the Responding Party agree at or prior to the expiration of such 30-day period
 (or any mutually agreed upon extension thereof) to the validity and amount of the claim,
 the Responding Party shall satisfy such obligations within 15 days of reaching such agreement.
 If the Claiming Party and the Responding Party do not agree within such period (or any mutually
 agreed upon extension thereof), the Responding Party and the Claiming Party agree that the
 parties will refer such matter to arbitration pursuant to Section 10.10, and once the claim
 is finally adjudicated to be payable pursuant to Section 10.10, the Responding Parties shall
 satisfy the obligations within 15 Business Days of such final, non-appealable adjudication.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.7** **Duty to Mitigate; Insurance** 

Nothing in this Agreement shall in any way restrict or limit the general obligation at Law of a Claiming Party to mitigate any loss or damage which it may suffer or incur by reason of the breach by a Responding Party of any representation, warranty, or covenant under this Agreement; and a Claiming Party shall be required to use commercially reasonable efforts to seek recovery, settlement, or otherwise from any other person. Without limiting the foregoing, to the extent any applicable Losses are reasonably likely to be recovered through any insurance policies, indemnities, or other reimbursement arrangements maintained or held by a Claiming Party, its Affiliates and/or each of their respective shareholders, officers, directors, employees and agents, then the Claiming Party shall (and shall procure that its Affiliates and its and their respective shareholders, officers, directors, employees and agents) use commercially reasonable efforts to make a claim and collect under such policies, and the amount of Losses suffered or incurred by the Claiming Party in respect of such claim shall be deemed to be reduced by any amounts actually received by the Claiming Party, its Affiliates and/or each of their respective shareholders, officers, directors, employees and agents under such policies as a result of the applicable matter giving rise to the applicable Losses, less any costs and expenses incurred in connection with any such recoveries, including any deductibles, if applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.8** **Double Recovery** 

A Claiming Party shall not be entitled to double recovery for any claim even though the claim may have resulted from the breach of more than one of the representations, warranties, and covenants made by the Responding Party in this Agreement. If the amount of any Losses incurred by a Claiming Party at any time subsequent to the receipt of a payment by the Responding Party under this Agreement is reduced by any recovery, settlement, or otherwise under or pursuant to any insurance coverage, or pursuant to any claim, recovery, settlement, or payment by or against any other person, the Claiming Party shall promptly notify the Responding Party in writing of the nature and amount of such reduction (and any costs, expenses or premiums directly incurred in connection therewith), and the amount of such reduction (less any such costs, expenses or premiums) shall promptly be paid by the Claiming Party to the Responding Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.9** **Exclusive Remedy** 

Save in the case of fraud, the provisions of this Article 9 (together with any other Article or Section referred to herein) constitute the sole monetary remedy available to the parties in respect of any claim for breach of covenants, representation, warranty or other obligation or provision of this Agreement and in respect of any and all other indemnities provided in this Agreement.

**ARTICLE IX**

10. **GENERAL PROVISIONS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.1** **Notices** 

All notices, requests, demands, claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim, or other communication hereunder shall be deemed duly given (i) when delivered personally to the recipient; (ii) when sent by electronic mail, on the date of transmission to such recipient if transmitted prior to 4:00 pm in the jurisdiction of the recipient, and if after 4:00 pm, then on the next Business Day in such jurisdiction; and (iii) one Business Day in the jurisdiction of the recipient after being sent to the recipient by reputable overnight courier service (charges prepaid); in each case, addressed to the intended recipient at its address specified on the signature page hereof or to such electronic mail address or address as subsequently modified by written notice given in accordance with this section. All communications shall be sent to the parties at the following information specified below (or at such other information for a party as shall be designated in advance written notice to the other parties hereto):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 to Company:

**Fusion Fuel Green Public Limited Company**

9 Pembroke Street Upper,

Dublin, Dublin,

D02 KR83

Ireland

Attention: Frederico Figueira De Chaves

Email: fchaves@fusion-fuel.eu

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If
 to Royal Uranium or the RU Shareholders:

**Royal Uranium Inc.**

Suite 2200, 885 West Georgia Street

Vancouver, British Columbia

V6C 3E8, Canada

Attention: Anthony Milewski

Email: anthony@blackvulcan.com

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.2** **Amendment** 

This Agreement may be amended by a subsequent writing signed by each of the parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.3** **Waiver** 

At any time prior to the Closing, any party hereto may with respect to any other party hereto (a) extend the time for performance of any of the obligations or other acts, (b) waive any inaccuracies in the representations and warranties contained herein or in any document delivered pursuant hereto, or (c) waive compliance with any of the agreements or conditions contained herein. Any such extension or waiver shall be valid if set forth in an instrument in writing signed by the party or parties to be bound thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.4** **Failure or Indulgence Not Waiver; Remedies Cumulative** 

No failure or delay on the part of any party hereto in the exercise of any right hereunder shall impair such right or be construed to be a waiver of, or acquiescence in, any breach of any representation, warranty or agreement herein, nor shall any single or partial exercise of any such right preclude other or further exercise thereof or of any other rights. Except as otherwise provided hereunder, all rights and remedies existing under this Agreement are cumulative to, and not exclusive of, any rights or remedies otherwise available.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.5** **Headings** 

The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.6** **Severability** 

If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the Transaction is not affected in any manner adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible, in a mutually acceptable manner, to the end that transactions contemplated hereby are fulfilled to the extent possible.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.7** **Entire Agreement** 

This Agreement constitutes the entire agreement and supersedes all prior agreements and undertakings both oral and written, among the parties, or any of them, with respect to the subject matter hereof and, except as otherwise expressly provided herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.8** **Assignment** 

No party may assign this Agreement or assign its respective rights or delegate their duties (by operation of Law or otherwise), without the prior written consent of the other parties. This Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and permitted assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.9** **No Third-Party Beneficiaries** 

This Agreement shall be binding upon and inure solely to the benefit of each party hereto and their permitted assigns and respective successors, and other than as expressly set forth herein, nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, including, without limitation, by way of subrogation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.10** **Arbitration** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 the parties are unable to resolve any claim, controversy, failure to agree, disagreement
 or dispute (each a "**Dispute**") between them arising under or related to
 this Agreement, such Dispute shall be submitted to arbitration by written demand of any party
 to the Dispute. To demand arbitration, a party (the "**Claimant**") shall
 give the other party (the "**Respondent**") a notice specifying the issues
 in dispute, the amount involved, the remedy requested and the name of the arbitrator the
 Claimant appoints (such Notice, a "**Notice of Dispute** "). Within twenty
 (20) Business Days after receipt of the Notice of Dispute, the Respondent shall answer the
 Notice of Dispute in writing, specifying the issues the Respondent disputes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 arbitration shall be determined by one (1) arbitrator to be agreed upon by the Claimant and
 the Respondent within ten (10) Business Days after the Respondent has responded to the Notice
 of Dispute. If the Claimant and the Respondent cannot agree on the appointment of an arbitrator,
 the Claimant and the Respondent shall refer the matter to the Vancouver International Commercial
 Arbitration Centre (the "**VanIAC**") and the VanIAC shall appoint the arbitrator.
 The arbitrator appointed by the Claimant and the Respondent or by the VanIAC shall be experienced
 and knowledgeable in respect of the matters in dispute as set out in the Notice of Dispute
 and any response to the Notice of Dispute. No person shall be appointed or selected as an
 arbitrator hereunder unless such person agrees in writing to serve. The selection of an arbitrator,
 either by agreement of the Claimant and the Respondent or by the VanIAC shall be final and
 binding on the Claimant and the Respondent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Except
 as specifically provided in this Section 10.10, arbitration hereunder shall be conducted
 in the English language in accordance with the current VanIAC commercial arbitration rules
 (the "**Rules** "). The seat of arbitration is Vancouver, British Columbia.
 The arbitrator shall fix a time and place in Vancouver, British Columbia reasonably convenient
 for the Claimant and the Respondent, after giving the Claimant and the Respondent not less
 than seven (7) Business Days' notice, for the purpose of hearing the evidence and representations
 of the Claimant and the Respondent and they shall preside over the arbitration and determine
 all questions of procedure not provided for under the Rules or this Section 10.10. After
 hearing any evidence and representations that the Claimant and the Respondent may submit,
 the arbitrator shall make a decision and reduce the same to writing and deliver one copy
 thereof to the Claimant and the Respondent. The arbitrator shall endeavor to make a decision
 within forty-five (45) days after its appointment, subject to any reasonable delay due to
 unavoidable circumstances. Any decision by the arbitrator shall follow and apply the Laws
 applicable to this Agreement pursuant to Section 10.11. The expense of the arbitration, including
 travel costs, expert witness and legal fees and costs shall be paid as determined in the
 discretion of the arbitrator, having due regard for the outcome of the arbitration and the
 relationship of the result to the positions taken by the Claimant and the Respondent. In
 the absence of fraud or manifest error, the decision of the arbitrator shall be final and
 binding upon each of the parties to the dispute.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.11** **Governing Law; Submission of Jurisdiction** 

This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia without giving effect to any choice or conflict of law provision or rule that would cause the application of the laws of any other jurisdiction. Each of the Parties hereby irrevocably attorns and submits to the arbitral jurisdiction set forth in Section 10.11 and, with respect to any matters not determined by arbitration, to the exclusive jurisdiction of the courts sitting in Vancouver, British Columbia, Canada and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.12** **Counterparts** 

This Agreement may be executed and delivered in one or more counterparts (including by electronic means and by electronic mail in portable document format), and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.13** **Representation** 

Each party to this Agreement represents that it: (a) has been represented in connection with the negotiation and preparation of this Agreement by counsel of that party's choosing (or has been given the opportunity to obtain independent legal advice and declined to seek such advice); (b) has authority to enter into and sign the Agreement; and (c) enters into and signs the same by its own free will.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.14** **Business Day** 

Whenever any action to be taken under this Agreement is required to be made or taken on a day other than a Business Day, such action taken on the next Business Day following such day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.15** **Interpretation** 

For purposes of this Agreement, references to the masculine gender shall include feminine and neuter genders and entities. Where a reference in this Agreement is made to a section or Annex, such reference shall be to a section of or Annex to this Agreement unless otherwise indicated. Whenever the words "include," "includes" or "including" are used in this Agreement, they shall be deemed to be followed by the words "without limitation." References to a "party" or "parties" shall mean Company, Royal Uranium and/or RU Shareholders, as applicable. The words "hereof," "herein" and "hereunder" and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.16** **Further Assurances** 

Each of the parties hereto will co-operate with the others and execute and deliver to the other parties hereto such other instruments and documents and take such other actions as may be reasonably requested from time to time by any other party hereto as necessary to carry out, evidence, and confirm the intended purposes of this Agreement.

[*Remainder of Page Intentionally Left Blank; Signature Pages to Follow*]

**IN WITNESS WHEREOF**, each of the parties has executed or caused this Share Exchange Agreement to be executed as of the date first written above.

---

| |
|:---|
| **FUSION FUEL GREEN PUBLIC LIMITED COMPANY** |
| By: |
| Name: |
| Title: |

---

---

| |
|:---|
| **[RU SHAREHOLDER]** |
| By: |
| Name: |
| Title: |

---

**Annex 1**

**CERTAIN DEFINITIONS**

The following terms, as used in the Agreement, have the following meanings:

"Affiliate(s)" shall have the meaning set forth in Rule 12b-2 of the regulations promulgated under the Securities Exchange Act of 1934, as amended.

"Alternative Acquisition" means any recapitalisation, restructuring, financing, merger, consolidation, sale, or other business combination transaction or extraordinary corporate transaction of Royal Uranium or the Company (as applicable) which would or could reasonably be expected to impede, interfere with, prevent or materially delay the transactions contemplated by this Agreement, including a firm proposal to make such an acquisition.

"Assets" of a Person shall mean all of the assets, properties, businesses and rights of such Person of every kind, nature, character and description, whether real, personal or mixed, tangible or intangible, accrued or contingent, or otherwise relating to or utilised in such Person's business, directly or indirectly, in whole or in part, whether or not carried on the books and records of such Person, and whether or not owned in the name of such Person or any Affiliate of such Person and wherever located.

"Business Day" means a day, other than a Saturday, Sunday or statutory holiday, when banks are generally open for the transaction of banking business in the City of Vancouver, British Columbia, Canada; New York, United States of America; Dublin, Ireland; and Lisbon, Portugal.

"Contract" means any written or oral agreement, arrangement, commitment, contract, indenture, instrument, lease, obligation, plan, restriction, understanding or undertaking of any kind or character, or other document to which any Person is a party or by which such Person is bound or affecting such Person's capital stock, Assets or business.

"Default" means (i) any breach or violation of or default under any Contract, Order or Permit, (ii) any occurrence of any event that with the passage of time or the giving of notice or both would constitute a breach or violation of or default under any Contract, Order or Permit, or (iii) any occurrence of any event that with or without the passage of time or the giving of notice would give rise to a right to terminate or revoke the current terms.

"GAAP" means generally the accepted accounting principles of the relevant jurisdiction.

"Governmental Entity" or "Governmental Authority" means any government or any agency, bureau, board, directorate, commission, court, department, official, political subdivision, tribunal, or other instrumentality of any government, whether federal, state or local, domestic or foreign.

"IFRS" means International Financial Reporting Standards.

"Irish Takeover Panel" means the statutory body responsible for monitoring and supervising takeovers and other relevant transactions in relevant companies in Ireland, established pursuant to the Irish Takeover Panel Act 1997, (as amended), and including any successor body thereto.

"Irish Takeover Panel Act 1997" means the Irish Takeover Panel Act 1997 (as amended from time to time), and any legislation re-enacting, consolidating or replacing the same.

"Knowledge" means in the case of Royal Uranium, the actual knowledge of the Representative Shareholders, and knowledge that a reasonable person in such capacity should have after due inquiry, and means in the case of any other party, the actual knowledge of the officers of a party, and knowledge that a reasonable person in such capacity should have after due inquiry.

"Law" means any code, law, ordinance, regulation, reporting or licensing requirement, rule, or statute applicable to a Person or its Assets, liabilities or business promulgated by any Governmental Entity.

"Lien" means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect to such asset.

"Loss" or "Losses" means all losses, damages, costs, expenses, penalties, fines and liabilities actually suffered or incurred and paid (including reasonable legal fees and disbursements); *provided that* "Loss" and "Losses" shall not include any indirect, consequential, special, punitive or exemplary damages.

"Material" and "Materially" for purposes of this Agreement shall be determined in light of the facts and circumstances of the matter in question, provided that any specific monetary amount stated in this Agreement shall determine materiality in that instance.

"Material Adverse Effect" means, with respect to any Person, a material adverse effect on the operations or financial condition of the, business, Assets, liabilities of such Person and its Subsidiaries taken as a whole; provided, however, that any adverse change, event, development or effect arising from or relating to any of the following shall not be taken into account in determining whether there has been a Material Adverse Effect (and therefore shall not constitute a Material Adverse Effect): (a) general business or economic conditions, (b) national or international political or social conditions, including the engagement by a jurisdiction in hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence of any military or terrorist attack upon a jurisdiction , or any of its territories, possessions, or diplomatic or consular offices or upon any military installation, equipment or personnel of such jurisdiction, (c) financial, banking, or securities markets (including any disruption thereof and any decline in the price of any security or any market index), (d) changes in generally accepted accounting principles of the relevant jurisdiction, (e) changes in laws, rules, regulations, orders, or other binding directives issued by any Governmental Entity, (f) any act of God, pandemics, natural disasters or similar calamities, or (g) the taking of any action required by this Agreement and the other agreements contemplated hereby.

"Order" means any administrative decision or award, decree, injunction, judgment, order, quasi-judicial decision or award, ruling, or writ of any Governmental Entity.

"Person" means an individual, a corporation, a partnership, an association, a trust, a limited liability company or any other entity or organisation, including a government or political subdivision or any agency or instrumentality thereof.

"Permit" means any federal, state, local, and foreign governmental approval, authorisation, certificate, consent, easement, filing, franchise, letter of good standing, license, notice, permit, qualification, registration or right of or from any Governmental Entity (or any extension, modification, amendment or waiver of any of these) to which any Person is a party or that is binding upon or inures to the benefit of any Person or its securities, Assets or business.

"Representative Shareholders" means collectively, Anthony Milewski and Mark Schipperheijn.

"Royal Uranium Data Room" means the documents relating to Royal Uranium and the transactions contemplated by this Agreement and which were sent by email from the Representative Shareholders to the CEO or the CFO of the Company, a copy of which is maintained by the Company.

"Royal Uranium Royalty Agreements" means the royalty agreements entered into by Royal Uranium in respect of the uranium royalty assets, as disclosed in the Royal Uranium Data Room.

"Resale Registration Statement" means a Registration Statement on Form F-3 under the Securities Act or a Registration Statement Form F-1 under the Securities Act.

"SEC" means the Securities and Exchange Commission.

"Securities Act" means the Securities Act of 1933, as amended.

"Subsidiary" means, with respect to any Person, (i) any corporation, limited liability company, association or other business entity of which more than 50% of the total voting power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof (as applicable) is at the time owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person (or a combination thereof) and (ii) any partnership (a) the sole general partner or managing general partner of which is such Person or a Subsidiary of such Person or (b) the only general partners of which are such Person or of one or more Subsidiaries of such Person (or any combination thereof).

"Transaction" means the transaction that is the subject of this Agreement.

"Transaction Documents" means the Agreement, and any other document executed and delivered pursuant hereto together with any exhibits or schedules to such documents.

**Annex 2**

**RU SHAREHOLDERS; ROYAL URANIUM SHARES; HTOO SHARES**

**Annex 3**

**FORM OF JOINDER AGREEMENT**

**JOINDER**

**TO THE SHARE EXCHANGE AGREEMENT**

---

| | |
|:---|:---|
| **To:** | **Royal Uranium Inc. ("Royal Uranium") and the Shareholders thereof (the "RU Shareholders")** |
| **And to:** | **Fusion Fuel Green Public Limited Company (the "Company")** |

---

All capitalized terms used but not defined herein shall have the meaning ascribed thereto in the Share Exchange Agreement (as defined below).

For valid consideration, I do hereby confirm and agree that:

(a) I
 am currently the registered holder of certain Royal Uranium Shares;

(b) I
 hereby consent to the exchange of the Royal Uranium Shares that I own for HTOO Shares, as set forth
 in the Share Exchange Agreement (as defined below);

(c) I
 hereby confirm that I have received a copy of the share exchange agreement (the "**Share Exchange Agreement**") entered into between the Company and certain RU Shareholders and I agree to be
 fully bound by the Share Exchange Agreement as a RU Shareholder (as defined therein), and acknowledge
 that I am subject to all of the covenants, terms and conditions of the Share Exchange Agreement and
 agree to observe, perform and be bound by all rights, duties and obligations of a RU Shareholder thereunder
 as though I was an original party to it, which includes the making of the representations and warranties
 of a RU Shareholder set forth in Section 2 of the Share Exchange Agreement;

(d) I
 hereby consent to any amendments or modifications to the terms of the Share Exchange Agreement, as may
 be agreed to by the Representative Shareholders (as defined in the Share Exchange Agreement) and the
 Company from time-to-time;

(e) I
 hereby further consent to the imposition by the Company of any restrictive legends on the HTOO Shares
 in connection with completion of transactions contemplated by the Share Exchange Agreement;

(f) I
 hereby confirm that I have been given the opportunity to seek independent legal and tax advice in connection
 with execution of this Joinder, and acknowledge that the transactions contemplated by the Share Exchange
 Agreement will have individual legal and tax consequences for which neither Royal Uranium nor the Company
 is taking responsibility.

    <br> *(Signature of Shareholder)* *(Name of Shareholder)*

 

**ANNEX 4**

**DEFINITION OF "ACCREDITED INVESTOR" UNDER RULE 501 OF REGULATION D OF THE SECURITIES ACT**

(a) **Accredited investor. Accredited investor** shall mean any person who comes within any of the following categories, or who the issuer reasonably believes comes within any of the following categories, at the time of the sale of the securities to that person:

&nbsp;&nbsp;&nbsp;&nbsp;(1) Any
 bank as defined in section 3(a)(2) of the Act, or any savings and loan association or other
 institution as defined in section 3(a)(5)(A) of the Act whether acting in its individual
 or fiduciary capacity; any broker or dealer registered pursuant to section 15 of the Securities
 Exchange Act of 1934; any investment adviser registered pursuant to section 203 of the Investment
 Advisers Act of 1940 or registered pursuant to the laws of a state; any investment adviser
 relying on the exemption from registering with the Commission under section 203(l) or (m)
 of the Investment Advisers Act of 1940; any insurance company as defined in section 2(a)(13)
 of the Act; any investment company registered under the Investment Company Act of 1940 or
 a business development company as defined in section 2(a)(48) of that act; any Small Business
 Investment Company licensed by the U.S. Small Business Administration under section 301(c)
 or (d) of the Small Business Investment Act of 1958; any Rural Business Investment Company
 as defined in section 384A of the Consolidated Farm and Rural Development Act; any plan established
 and maintained by a state, its political subdivisions, or any agency or instrumentality of
 a state or its political subdivisions, for the benefit of its employees, if such plan has
 total assets in excess of $5,000,000; any employee benefit plan within the meaning of the
 Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan
 fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan
 association, insurance company, or registered investment adviser, or if the employee benefit
 plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment
 decisions made solely by persons that are accredited investors;

&nbsp;&nbsp;&nbsp;&nbsp;(2) Any
 private business development company as defined in section 202(a)(22) of the Investment Advisers
 Act of 1940;

&nbsp;&nbsp;&nbsp;&nbsp;(3) Any
 organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts
 or similar business trust, partnership, or limited liability company, not formed for the
 specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

&nbsp;&nbsp;&nbsp;&nbsp;(4) Any
 director, executive officer, or general partner of the issuer of the securities being offered
 or sold, or any director, executive officer, or general partner of a general partner of that
 issuer;

&nbsp;&nbsp;&nbsp;&nbsp;(5) Any
 natural person whose individual net worth, or joint net worth with that person's spouse
 or spousal equivalent, exceeds $1,000,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Except
 as provided in paragraph (a)(5)(ii) of this section, for purposes of calculating net worth
 under this paragraph (a)(5):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. The
 person's primary residence shall not be included as an asset;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Indebtedness
 that is secured by the person's primary residence, up to the estimated fair market
 value of the primary residence at the time of the sale of securities, shall not be included
 as a liability (except that if the amount of such indebtedness outstanding at the time of
 sale of securities exceeds the amount outstanding 60 days before such time, other than as
 a result of the acquisition of the primary residence, the amount of such excess shall be
 included as a liability); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Indebtedness
 that is secured by the person's primary residence in excess of the estimated fair market
 value of the primary residence at the time of the sale of securities shall be included as
 a liability.

Note 1 to paragraph (a)(5):

For the purposes of calculating joint net worth in this <u>paragraph (a)(5)</u>: Joint net worth can be the aggregate net worth of the investor and spouse or spousal equivalent; assets need not be held jointly to be included in the calculation. Reliance on the joint net worth standard of this <u>paragraph (a)(5)</u> does not require that the securities be purchased jointly.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Paragraph
 (a)(5)(i) of this section will not apply to any calculation of a person's net worth
 made in connection with a purchase of securities in accordance with a right to purchase such
 securities, provided that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Such
 right was held by the person on July 20, 2010;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. The
 person qualified as an accredited investor on the basis of net worth at the time the person
 acquired such right; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. The
 person held securities of the same issuer, other than such right, on July 20, 2010.

&nbsp;&nbsp;&nbsp;&nbsp;(6) Any
 natural person who had an individual income in excess of $200,000 in each of the two most
 recent years or joint income with that person's spouse or spousal equivalent in excess
 of $300,000 in each of those years and has a reasonable expectation of reaching the same
 income level in the current year;

&nbsp;&nbsp;&nbsp;&nbsp;(7) Any
 trust, with total assets in excess of $5,000,000, not formed for the specific purpose of
 acquiring the securities offered, whose purchase is directed by a sophisticated person as
 described in §230.506(b)(2)(ii);

&nbsp;&nbsp;&nbsp;&nbsp;(8) Any
 entity in which all of the equity owners are accredited investors;

Note 1 to paragraph (a)(8):

It is permissible to look through various forms of equity ownership to natural persons in determining the accredited investor status of entities under this <u>paragraph (a)(8)</u>. If those natural persons are themselves accredited investors, and if all other equity owners of the entity seeking accredited investor status are accredited investors, then this <u>paragraph (a)(8)</u> may be available.

&nbsp;&nbsp;&nbsp;&nbsp;(9) Any
 entity, of a type not listed in paragraph (a)(1), (2), (3), (7), or (8), not formed for the
 specific purpose of acquiring the securities offered, owning investments in excess of $5,000,000;

Note 1 to paragraph (a)(9):

For the purposes this <u>paragraph (a)(9)</u>, "investments" is defined in rule 2a51-1(b) under the Investment Company Act of 1940 (<u>17 CFR 270.2a51-1(b</u>)).

&nbsp;&nbsp;&nbsp;&nbsp;(10) Any
 natural person holding in good standing one or more professional certifications or designations
 or credentials from an accredited educational institution that the Commission has designated
 as qualifying an individual for accredited investor status. In determining whether to designate
 a professional certification or designation or credential from an accredited educational
 institution for purposes of this paragraph (a)(10), the Commission will consider, among others,
 the following attributes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The
 certification, designation, or credential arises out of an examination or series of examinations
 administered by a self-regulatory organization or other industry body or is issued by an
 accredited educational institution;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The
 examination or series of examinations is designed to reliably and validly demonstrate an
 individual's comprehension and sophistication in the areas of securities and investing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Persons
 obtaining such certification, designation, or credential can reasonably be expected to have
 sufficient knowledge and experience in financial and business matters to evaluate the merits
 and risks of a prospective investment; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) An
 indication that an individual holds the certification or designation is either made publicly
 available by the relevant self-regulatory organization or other industry body or is otherwise
 independently verifiable;

Note 1 to paragraph (a)(10):

The Commission will designate professional certifications or designations or credentials for purposes of this <u>paragraph (a)(10)</u>, by order, after notice and an opportunity for public comment. The professional certifications or designations or credentials currently recognized by the Commission as satisfying the above criteria will be posted on the Commission's website.

&nbsp;&nbsp;&nbsp;&nbsp;(11) Any
 natural person who is a "knowledgeable employee," as defined in rule 3c-5(a)(4)
 under the Investment Company Act of 1940 (17 CFR 270.3c-5(a)(4)), of the issuer of the securities
 being offered or sold where the issuer would be an investment company, as defined in section
 3 of such act, but for the exclusion provided by either section 3(c)(1) or section 3(c)(7)
 of such act;

&nbsp;&nbsp;&nbsp;&nbsp;(12) Any
 "family office," as defined in rule 202(a)(11)(G)-1 under the Investment Advisers
 Act of 1940 (17 CFR 275.202(a)(11)(G)-1):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) With
 assets under management in excess of $5,000,000,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) That
 is not formed for the specific purpose of acquiring the securities offered, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Whose
 prospective investment is directed by a person who has such knowledge and experience in financial
 and business matters that such family office is capable of evaluating the merits and risks
 of the prospective investment; and

&nbsp;&nbsp;&nbsp;&nbsp;(13) Any
 "family client," as defined in rule 202(a)(11)(G)-1 under the Investment Advisers
 Act of 1940 (17 CFR 275.202(a)(11)(G)-1)), of a family office meeting the requirements in
 paragraph (a)(12) of this section and whose prospective investment in the issuer is directed
 by such family office pursuant to paragraph (a)(12)(iii).

## Exhibit 99.1

**Exhibit 99.1**

**Fusion Fuel Inks Transformational Agreement to Acquire a Portfolio of Nineteen High-Quality Uranium & Gas Royalties Based in the Americas**

● *Acquisition is expected to provide key exposure to uranium and natural gas markets, both experiencing some of the highest growth in global demand due to their roles in energy security, decarbonization, and the rising power needs of AI-driven data centers* 

● *Portfolio includes sixteen (16) uranium and three (3) natural gas royalties being developed and explored by industry leaders such as Cameco, IsoEnergy, Uranium Energy Corp., among others* 

 

Dublin, February 18, 2026 — Fusion Fuel Green PLC (NASDAQ:HTOO) ("Fusion Fuel" or the "Company"), an integrated green energy engineering, distribution, and solutions provider, is pleased to announce that it has entered into a definitive agreement to acquire a controlling interest in Royal Uranium Inc. ("Royal Uranium"), a diversified portfolio of uranium royalties spanning the exploration and development sectors of the mining cycle (the "Portfolio"), in a strategic share exchange transaction.

This acquisition is expected to provide Fusion Fuel with direct exposure to one of the most compelling and increasingly fundamental asset classes supporting global energy security and the rapid expansion of AI-driven infrastructure and the nuclear power required to support it.

**A Strategic Entry into Clean Energy Royalties**

By gaining meaningful exposure to sixteen (16) uranium and three (3) natural gas royalties in the Americas, Fusion Fuel believes that it is poised to secure long-term economic participation in the energy sources increasingly required to power AI infrastructure, electrification and global decarbonization. The acquisition is expected to position Fusion Fuel at the intersection of three powerful structural trends:

&nbsp;&nbsp;&nbsp;&nbsp;1. The
 accelerating global demand for electricity driven by the need for enhanced power security
 and the increasing demand from AI and data center infrastructure;

&nbsp;&nbsp;&nbsp;&nbsp;2. A
 growing structural supply deficit in uranium, alongside a renewed global commitment to nuclear
 energy as a critical source for reliable, low-carbon baseload power; and

&nbsp;&nbsp;&nbsp;&nbsp;3. An
 increasing strategic focus on secure, regional access to critical energy materials, particularly
 within the Americas, as governments and industries prioritize supply chain resilience, energy
 independence and regional security.

Global data center power demand is expected to grow more than 160% by 2030, with AI-related power demand projected to increase materially over the balance of the decade.<sup>1</sup> At the same time, uranium demand is forecast to increase significantly through 2040, with supply growth lagging demand, creating a structural deficit environment.<sup>2</sup>

**Sources**

<sup>1</sup> <u>https://www.goldmansachs.com/images/migrated/insights/pages/gs-research/gs-sustain-generational-growth-ai-data-centers-global-power-surge-and-the-sustainability-impact/sustain-data-center-redaction.pdf</u>

<sup>2</sup> <u>https://redcloudfs.com/the-global-uranium-market-in-3-charts/#:~:text=Despite%20these%20risks%2C%20the%20demand,to%20achieve%20zero%2Dcarbon%20targets</u>

**High-Quality Uranium Exposure in Tier-One Jurisdictions with World Class Partners**

The Portfolio includes royalties from some of the globe's most significant uranium miners operating projects located in world-class uranium districts, including:

● The **Athabasca Basin**, one of the world's highest-grade uranium regions;

● The advanced-stage **Berlin Project** in Colombia, with historical resources and meaningful expansion potential; and

● Additional projects across Argentina and Newfoundland and Labrador.

**Immediate Cash Flow and Energy Diversification**

The diversified royalty base is expected to provide exposure across multiple uranium operations, development stages and jurisdictions — while avoiding direct operating risk and capital intensity typically associated with mining companies.

In addition to uranium royalties, the Portfolio includes producing Alberta natural gas royalties that are operating and already generate cash flow. Natural gas provides reliable, dispatchable baseload power and complements nuclear energy in supporting expanding data center infrastructure.

These producing royalties are expected to provide near-term revenue while maintaining leverage to long-term structural energy demand growth.

**A Capital-Efficient, High-Margin Business Model**

The royalty structure is expected to provide Fusion Fuel with:

● Long-term revenue participation without operating cost exposure;

● No capital expenditure obligations;

● High-margin, scalable cash flow potential; and

● Embedded leverage to uranium and natural gas price appreciation.

As uranium markets move deeper into structural supply deficits and nuclear energy regains global policy support, the embedded optionality within this royalty Portfolio has the potential to significantly enhance shareholder value.

**Transformational Impact for Fusion Fuel**

This acquisition is expected to materially strengthen Fusion Fuel's strategic positioning and significantly enhance its exposure to a rapidly appreciating and increasingly essential asset class.

By securing a diversified Portfolio of clean energy royalties, Fusion Fuel is expected to:

● Enter a supply-constrained commodity cycle with strong structural fundamentals;

● Align with long-term global electrification and AI infrastructure growth;

● Establish a scalable platform for additional royalty acquisitions; and

● Enhance long-term asset value and enterprise optionality.

Management believes this transaction represents a foundational step in building a differentiated clean energy royalty platform focused on powering the next generation of global energy demand.

**Company Insights**

"By agreeing to acquire exposure to uranium and clean energy royalties, we are entering an asset class that is experiencing strong structural growth and is increasingly central to global energy development," said JP Backwell, Chief Executive Officer of Fusion Fuel. "As electrification accelerates and AI-driven infrastructure continues to expand, reliable and scalable clean energy sources, in particular nuclear energy, are expected to play a critical role. We believe this acquisition meaningfully enhances our long-term strategic positioning and supports our ambition to meaningfully participate in the energy systems that will underpin future global growth. As we move forward, our aim is to expand on this strong starting Portfolio in the uranium and nuclear related industries."

Frederico Figueira de Chaves, Fusion Fuel's Interim Chief Financial Officer and Chief Strategy Officer, noted, "We believe this acquisition is highly compelling from both a financial and strategic standpoint. The Portfolio comprises high-quality royalty assets that offer attractive long-term optionality. Importantly, these assets are expected to provide exposure to potential upside without requiring additional capital investment by the Company. In addition, we believe this positions Fusion Fuel to be a valuable and strong option for those interested in exposure to the expected growth for the nuclear industry and energy transition in general. This transaction reflects our disciplined, capital-efficient approach to value creation, and we intend to continue to evaluate and cultivate similar strategic opportunities as we build and expand our clean energy royalty platform."

**Transaction Details**

Fusion Fuel has entered into a definitive Share Exchange Agreement dated February 18, 2026 (the "Agreement") with certain shareholders of Royal Uranium, pursuant to which Fusion Fuel is expected to acquire between 75-100% of the shares of Royal Uranium, in consideration for the allotment of up to 3,750,025 shares in Fusion Fuel to the current shareholders of Royal Uranium.

Closing of the transaction is subject to certain conditions, including but not limited to:

● approval by the Irish Takeover Panel (the "Panel") in accordance with the Irish Takeover Panel Act, 1997, Takeover Rules, 2022, of a circular prepared by Fusion Fuel to be issued to Fusion Fuel shareholders, convening an extraordinary general meeting of the Company (the "EGM");

● Fusion Fuel shareholder approval of the share exchange transaction at the EGM; and

● Satisfaction of such conditions and compliance with such requirements as the Panel may impose or specify in relation to the transaction.

The transaction is expected to close in the first half of 2026. A further description of the terms and conditions of the transaction has been separately disclosed in a Form 6-K furnished today with the U.S. Securities and Exchange Commission (the "SEC").

**About Fusion Fuel Green PLC**

Fusion Fuel Green PLC (NASDAQ: HTOO) provides integrated energy engineering, distribution, and green hydrogen solutions through its Al Shola Gas, BrightHy Solutions, and BioSteam Energy platforms. With operations spanning LPG supply to hydrogen and bio-steam solutions, the Company supports decarbonization across industrial, residential, and commercial sectors. For more information, please <u>visit www.fusion-fuel.eu</u>.

**About Royal Uranium Inc.**

Royal Uranium is a private energy royalty entity holding a Portfolio of tier one high-quality uranium and natural gas royalties across premier mining jurisdictions in the Americas, operated by experienced industry partners. The Portfolio is designed to provide long-duration exposure to commodity price upside while minimizing operating risk through the royalty model. For more information, please visit <u>www.royaluranium.com</u>.

**Forward-Looking Statements**

This press release and the statements contained herein include "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or the Company's future financial or operating performance. In some cases, you can identify these statements because they contain words such as "may," "will," "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," "plan," "target," "predict," "potential," or the negative of such terms, or other comparable terminology that concern the Company's expectations, strategy, plans, or intentions. Forward-looking statements relating to expectations about future results or events are based upon information available to the Company as of today's date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. The Company's expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the parties' ability to complete the transaction, the Company's ability to integrate Royal Uranium's assets into its business, the ability of the parties to obtain Irish regulatory approval and any other required third-party consents and approvals in connection with the transaction, obtain the approval of the Company's shareholders, and to meet all other closing conditions; the realization of revenues from the assets of Royal Uranium, including its uranium and natural gas royalties, which may depend on, among other things, the degree of success in obtaining regulatory acceptance of, and market demand for, uranium and natural gas as sources of energy; competition from existing or new offerings that may emerge; impacts from strategic changes to the Company's business on net sales, revenues, income from continuing operations, or other results of operations; the Company's ability to obtain sufficient funding to maintain operations and develop additional services and offerings; and the risks and uncertainties described under Item 3. "Key Information – D. Risk Factors" and elsewhere in the Company's Annual Report on Form 20-F filed with the SEC on May 9, 2025 (the "Annual Report"), and other filings with the SEC. Should any of these risks or uncertainties materialize, or should the underlying assumptions about the Company's business and the commercial markets in which the Company operates prove incorrect, actual results may vary materially from those described as anticipated, estimated or expected in the Annual Report. All subsequent written and oral forward-looking statements concerning the Company or other matters and attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. The Company does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof, except as required by law.

**Responsibility Statement**

The directors of Fusion Fuel (the "Directors") accept responsibility for the information contained in this announcement other than that relating to Royal Uranium and, to the best of the knowledge and belief of the Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

**Investor Relations Contact**

ir@fusion-fuel.eu

www.fusion-fuel.eu